List of Confirmed Keynote Speakers

80
TOSHIHIRO AKAIKE Principal Investigator/Director, FAIS Biomaterials Center for Regenerative Medical Engineering 24-16, Kasuga 3-Chome, Tsukuba, Ibaraki 305-0821, Japan Phone: +81-29-858-7520 Email: [email protected] Biography Education and Carrier: 2014- present: Principal Investigator, Director FAIS Biomaterials Center for Regenerative Medical Engineering, Tsukuba, Japan. 2012- 2014: Professor Emeritus, Professor of Donated Chair, Biomaterials Design for Regenerative Engineering, Tokyo Institute of Technology, Japan. 2009 to 2012: Professor, Frontier Research Center & Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Japan. 2009 to present: Visiting Professor, School of Medicine, Tsinghua University , China. 2009 to present: Visiting Professor, Nankai University, China. 1990 to 2009: Professor, Graduate School of Bioscience and Biotechnology, Dept. of Bio- molecular Engineering, Tokyo Institute of Technology, Japan, 2000 to 2003: Professor, Graduate School of Medicine, Shinshu University, Nagano, Japan. 1989 to 1995: Project Leader, Akaike Project “High-functional Membrane for Molecular Recognition”, Kanagawa Academy of Sci. & Tech., Japan. 1980 to 1990: Associate Professor, Dept of Material Systems Engineering, Faculty of Engineering, Tokyo University of Agriculture and Technology. Japan. Honors: Tokyo Tech Award for the Best Teacher (2007) Fellow, Biomaterials Science and Engineering, The International Union of Societies for Biomaterials Science and Engineering (2004) Jorge Heller Journal of Controlled Release/CRS Outstanding Paper Award (1997) Scientific Achievement Award, The Japanese Society for Biomaterials (1989)

Transcript of List of Confirmed Keynote Speakers

Page 1: List of Confirmed Keynote Speakers

TOSHIHIRO AKAIKE Principal Investigator/Director, FAIS Biomaterials Center for Regenerative Medical Engineering 24-16, Kasuga 3-Chome, Tsukuba, Ibaraki 305-0821, Japan Phone: +81-29-858-7520 Email: [email protected]

Biography Education and Carrier: 2014- present: Principal Investigator, Director FAIS Biomaterials Center for Regenerative Medical Engineering, Tsukuba, Japan. 2012- 2014: Professor Emeritus, Professor of Donated Chair,

Biomaterials Design for Regenerative Engineering, Tokyo Institute of Technology, Japan. 2009 to 2012: Professor, Frontier Research Center & Graduate School of Bioscience and Biotechnology,

Tokyo Institute of Technology, Japan. 2009 to present: Visiting Professor, School of Medicine, Tsinghua University , China. 2009 to present: Visiting Professor, Nankai University, China. 1990 to 2009: Professor, Graduate School of Bioscience and Biotechnology, Dept. of Bio- molecular

Engineering, Tokyo Institute of Technology, Japan, 2000 to 2003: Professor, Graduate School of Medicine, Shinshu University, Nagano, Japan. 1989 to 1995: Project Leader, Akaike Project “High-functional Membrane for Molecular Recognition”,

Kanagawa Academy of Sci. & Tech., Japan. 1980 to 1990: Associate Professor, Dept of Material Systems Engineering, Faculty of Engineering, Tokyo University of Agriculture and Technology. Japan. Honors: Tokyo Tech Award for the Best Teacher (2007) Fellow, Biomaterials Science and Engineering, The International Union of Societies for Biomaterials Science and Engineering (2004) Jorge Heller Journal of Controlled Release/CRS Outstanding Paper Award (1997) Scientific Achievement Award, The Japanese Society for Biomaterials (1989)

Page 2: List of Confirmed Keynote Speakers

Eben Alsberg, PhD. Professor, Case Western Reserve University Email: [email protected]

Cleveland, OH, USA

Biography

Dr. Alsberg took a faculty position in 2005 at Case Western Reserve University, where he is currently a professor of Biomedical Engineering and Orthopaedic Surgery and serves as Director of the Stem Cell and Engineered Novel Therapeutics Laboratory. His lab focuses on the engineering of new technologies to regenerate tissues and treat diseases through the development of novel biomaterials and microenvironments. He has co-authored ~90 peer reviewed papers and book chapters and ~170 abstracts and conference proceedings. His work has been recognized with the 2008 Ellison Medical Foundation New Scholar in Aging Award and the Crain’s Cleveland Business 2009 Forty Under 40 Award, and he was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. The NIH, DOD, NSF, the Ellison Medical Foundation, the Coulter Foundation, the Musculoskeletal Transplant Foundation, the State of Ohio and the AO Foundation have supported his lab’s research.

Page 3: List of Confirmed Keynote Speakers

Hamdan S. Alghamdi, MSc, PhD Director, College of Dentistry Research Center (CDRC) Assistant Professor Periodontics & Oral Implants King Saud University Visiting Research Ass. Professor Radboud University Email: [email protected] RIYADH, SAUDI ARABIA

Biography Hamdan S. Alghamdi studied dentistry at King Saud University in Riyadh (Saudi Arabia). From 2003 to 2006, he successfully completed an advanced clinical training in periodontology and oral implantology at the College of Dentistry, King Saud University. In 2007, he received his master degree (MSc) in dental sciences from King Saud University. In July 2010, Hamdan started a PhD study under the supervision of Professor John Jansen in the Department of Biomaterials, Radboud University Medical Center, Nijmegen (The Netherlands). The aim of the PhD study was to evaluate the osteogenic potential of dental implant surface with different modifications in osteoporotic conditions. During his PhD work, he participated in several inter(national) conferences and meetings in the field of biomaterials and bone regeneration and oral implantology. Hamdan Alghamdi is currently appointed as an assistant professor and Director of Research Center at the College of Dentistry, King Saud University, Riyadh (Saudi Arabia). Dr. Alghamdi has also been affiliated as a visiting research assistant professor at the Department of Biomaterials and Oral Implantology in Radboud University Medical Center, Nijmegen, The Netherlands. He is also involving in several collaborative research activities and PhD students supervision with Radboud University. Dr. Alghamdi was able to author or co-author several publications in top ISI-journals in the field of biomaterials and tissue engineering of oral implantology. He is a participant in the Society for Biomaterials (in USA) and the Tissue Engineering and Regenerative Medicine International Society (TERMIS). He is continually attending annual meeting of the Society for Biomaterials as well as TERMIS. As a result, Dr. Alghamdi is able to develop a wide scientific networking in the field of Biomaterials and Tissue Engineering.

Page 4: List of Confirmed Keynote Speakers

Eric Brey Professor, Biomedical Engineering, Illinois Institute of Technology Research Health Scientist, Edward J. Hines Veterans Administration Hospital U.S.A

Biography

Eric Brey is Duchossois Leadership Professor of Biomedical Engineering at the IllinoisInstitute of Technology and Research Health Scientist at Hines Veterans Administration Hospital. He received B.S. and MEng degrees in Chemical Engineering from the University of Louisville and a Ph.D. in Chemical Engineering from Rice University. He served ass a National Institutes of Health post-doctoral Fellow in the Departments of Surgery and Cell Biology at Loyola University Medical Center. Professor Brey has contributed to new methods for engineering vascularized tissues and imaging methods for analysis of engineered tissues. Professor Brey’s research has resulted in over 100 peer-reviewed publications, 9 book chapters and one book. He is a fellow of the American Institute for Medical and Biological Engineers. He has received numerous awards, including the 2015 TERMIS Educational Award, a Young Investigator Award from the International Society of Applied Cardiovascular Biology, and a Sigma Xi Award for Excellence in Research.

Page 5: List of Confirmed Keynote Speakers

Barbara Chan Associate Professor, Tissue Engineering Laboratory, Medical Engineering, Department of Mechanical Engineering, The University of Hong Kong Hong Kong

Biography

Dr. Chan completed her undergraduate studies in Biochemistry at the Chinese University of Hong Kong in 1994. She obtained her Ph.D. in Surgical Science Division of the Faculty of Medicine from CUHK in 1998 and finished her first post-doctoral fellowship in Orthopaedics and Traumatology in the same institution in 1999. Dr. Chan then joined the Innovation and Technology Commission participating in the operation of the Small Entrepreneur Research Assistant Program under the Innovation and Technology Fund. After a one-year service in the government, she received her second postdoctoral fellowship in the Wellman Laboratories for Photomedicine, Massachusetts General Hospital in Harvard Medical School. Dr. Chan moved back to Hong Kong in 2002 and worked in the CK Life Sciences Int’l Inc. as a project manager. She joined the Department of Mechanical Engineering in the University of Hong Kong in 2003. Her main research interests are tissue engineering and regeneration, biosurgery, laser medicine, stem cells and biomaterial interactions, and mechanoregulation.

Page 6: List of Confirmed Keynote Speakers

Hsin-Cheng Chiu, Ph.D. Professor, Department of Biomedical Engineering and Environmental Sciences National Tsing Hua University Hsinchu City, Taiwan

Biography

Dr. Chiu received his Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah in 1994. After serving as a faculty member in the Department of Chemical Engineering at National Chung Tsing University for 15 years, he moved to National Tsing Hua University in 2009. Dr. Chiu has a professional background in design, synthesis and development of stimuli-responsive supramolecular nanoconstructs for targeted delivery and controlled release of therapeutics. His current interests concentrate on exploiting smart nanomedicines for cancer theranostic applications and using tumortropic immune/stem cells as Trojan vehicles to deliver therapeutics and diagnostics to tumors that are more difficult to be treated with conventional nanomedicine delivery approaches. He has published more than 60 peer-reviewed research articles. His work has been recognized by, for examples, receiving the Award of Excellence in Research from Li Chio Zen Biomaterial Research Foundation, Academic Excellence Award of National Tsing Hua University, and Outstanding Research Award of National Chung Hsing University.

Page 7: List of Confirmed Keynote Speakers

Karen L. Christman Associate Professor of Department of Bioengineering Sanford Consortium for Regenerative Medicine University of California, San Diego La Jolla, California, U.S.A.

Biography

Dr. Christman received her B.S. in Biomedical Engineering from Northwestern University in 2000 and her Ph.D. from the University of California San Francisco and Berkeley Joint Bioengineering Graduate Group in 2003, where she examined in situ approaches to myocardial tissue engineering. She was also a NIH postdoctoral fellow at the University of California, Los Angeles in the fields of polymer chemistry and nanotechnology. Dr. Christman joined the Department of Bioengineering in 2007 and is a member of the Institute of Engineering in Medicine at the University of California, San Diego. Her lab, which is housed in the Sanford Consortium for Regenerative Medicine, focuses on developing novel biomaterials for tissue engineering and regenerative medicine applications, and has a strong translational focus with the main goal of developing minimally invasive therapies for cardiovascular disease. Dr. Christman is a fellow of the American Heart Association, and has received several awards including the NIH Director’s New Innovator and Transformative Research Awards, the Wallace H. Coulter Foundation Early Career Translational Research Award, the American Heart Association Western States Innovative Sciences Award, and the Tissue Engineering and Regenerative Medicine Society’s Young Investigator Award. Dr. Christman is also co-founder of Ventrix, Inc., which is starting clinical trials with the cardiac extracellular matrix hydrogel technology developed in her lab at UCSD.

Page 8: List of Confirmed Keynote Speakers

Guoping Chen Professor, Joint Doctoral Program in Materials Science and Engineering, Graduate School of Pure and Applied Science, University of Tsukuba Japan

Biography

Dr. Guoping Chen obtained his Ph.D. from Kyoto University in 1997 majoring in biomaterials and did postdoctoral research until 2000. He became Rresearcher in 2000 and Senior Researcher in 2003 at Tissue Engineering Research Center, National Institute for Advanced Industrial Science and Technology. He moved to Biomaterials Center, National Institute for Materials Science as Senior Researcher in 2004 and was Group Leader from January, 2007 to March, 2011. He was Principal Investigator and Unit Director of Tissue Regeneration Materials Unit from April, 2011 to March, 2015. He holds current position since April, 2015. He is also Professor of Joint Doctoral Program in Materials Science and Engineering, Graduate School of Pure and Applied Science, University of Tsukuba and Fellow of the Royal Society of Chemistry. His research interests include tissue engineering, polymeric porous scaffolds, nonabiomaterials, biomimetic biomaterials, nano/micro-patterning and surface modification. He has authored more than 230 publications and holds 14 patents. He is Associate Editor of Journal of Materials Chemistry B; Editor of Science China Chemistry and Editorial Board of Journal of Bioactive and Compatible Polymers and Tissue Engineering (Parts A, B and C).

Page 9: List of Confirmed Keynote Speakers

Nai-Chen Cheng, MD, PhD

Clinical Assistant Professor,

Department of Surgery,

National Taiwan University Hospital,

Taipei, Taiwan

Biography

As a plastic surgeon, Naichen Cheng often deals with various clinical problems with human tissue deficiency, so his research has been focused on applying adipose-derived stem cells (ASCs)

in various regenerative purposes. He joined Professor Farshid Guilak’s bioengineering laboratory

in Duke University Medical Center in 2007, and the team successfully applied ASCs on native tissue-derived scaffolds to make cartilage-like tissue. This series of study have been published in Tissue Engineering and Regenerative Medicine. After returning to Taiwan in 2009, Dr. Cheng further investigated the scaffold-free 3D culture techniques to fabricate ASC spheroids and sheets. His team has successfully applied ASC spheroids and sheets to enhance tissue regeneration in animal models of cutaneous wound healing. This series of study have been published in Biomaterials and Stem Cells Translational Medicine. Currently, he aims at the clinical translation of the 3D ASC culture techniques to promote wound healing in diabetic patients.

Page 10: List of Confirmed Keynote Speakers

Hyung Joon Cha Director, Marine BioMaterials Research Center Research Director, National Research Laboratory of Molecular Biotechnology Pohang University of Science and Technology Korea

Biography

Hyung Joon Cha is the SeA Chair Professor of Department of Chemical Engineering at POSTECH. He received his PhD in Chemical Engineering from Seoul National University in 1995. From 1996 to 1998, he was Postdoctoral Associate in University of Maryland Biotechnology Institute, USA and the Assistant Research Professor of Department of Chemical Engineering at University of Maryland, College Park in 1998-1999. He joined POSTECH in 1999. His area of interests includes protein-based biomaterials, tissue and biomedical engineering, and biochip-based diagnosis. He has published ~180 peer-reviewed research papers and holds more than 80 issued patents. Currently, he is the Director of Marine BioMaterials Research Center funded by the Ministry of Oceans and Fisheries, Korea through recognition of his prominent works on mussel-derived adhesive biomaterials for tissue and biomedical applications. His work has been recognized by a 2020 Future 100 Best Technologies and Researchers award of the National Academy of Engineering of Korea, a 2012 National R&D 100 Best Researches award of the Ministry of Education, Science, and Technology, a Song-Gok Science and Technology Award of the Korea Institute of Science and Technology, a Beom-Seok Research Award of the Korea Institute of Chemical Engineering, a Dam-Yeon Research Award of the Korean Society for Biotechnology and Bioengineering, and so on. He is the Associate Editor of Korean Journal of Chemical Engineering, the Associate Editor of Applied Biochemistry and Biotechnology, and the Associate Editor of BMC Biotechnology.

Page 11: List of Confirmed Keynote Speakers

Ming-Huei Cheng, MD, MBA, FACS Professor, Department of Plastic and Reconstructive Surgery, Chief, Center for Tissue Engineering, Chairman, International Medical Center, Vice President, Chang Gung Memorial Hospital, Email: [email protected]; [email protected]

Linko, Taiwan

Biography

Ming- Huei Cheng is currently Vice president at Chang Gung Memorial Hospital, Linko, Taiwan. He is also the Chairman of International Medical Center. He is the author or co-author of more than 150 peer-reviewed journal articles as well as over 28 book chapters and 2 books. He has been invited as the visiting professor and gave more than hundreds lectures around the world. His research is focusing on tissue engineering which eventually will apply in clinical use. As a surgeon, he gets in contact with patients and receive first-hand information regarding the medical issues from his work. Those clinical experiences is helpful for designing and focusing on solving clinical problems. Currently, he organized a research team with experts from different backgrounds to establish a Center for Tissue Engineering in Chang Gung Memorial Hospital.

His lab provides a nice platform to evaluate the efficacy of the biomaterials or application of adult

stem cells in the animal model which is just one step before clinical trials. The main research projects are focusing on the tissue engineering with an integrated use of stem cells (Adipose stem cells and Bone marrow stem cells), biomaterial scaffolds (PEG, PCL-PLLA…etc.) and bioreactors (in vivo culture systems designed to mimic the growth environment of living tissue). His group currently conducts research in the areas of 1) Adult stem cell application, 2) Tissue engineering in trachea, cartilage, bone and lipid. 3) Trachea regeneration, 4) Wound healing therapy, 5) Lymphedema development and therapy, 6) Bioreactor and biomaterial development.

Page 12: List of Confirmed Keynote Speakers

Jiang Chang Associate Editor of Journal of Materials Chemistry B Professor of Biomaterials Biomaterials and Tissue Engineering Research Center Shanghai Institute of Ceramics, Chinese Academy of Sciences Shanghai, China

Biography

Jiang Chang is a Professor of the Biomaterials and Tissue Engineering Research Center at the Shanghai Institute of Ceramics (since 2000), and Adjunct Professor at Shanghai Jiaotong University School of Biomedical Engineering/Med-X Research Institute. He received his PhD in Chemistry from the Technical University of Darmstadt in Germany. His research focuses on bioactive materials for tissue regeneration and tissue engineering and the mechanisms of the interaction between biomaterials and cells. Professor Chang is the vice president of the Interdisciplinary Research Society for Bone and Joint Injectable Biomaterials. He is a Fellow of International Union of Societies for Biomaterials Science and Engineering (FBSE), and a Fellow of Royal Society of Chemistry, (FRSC). He is also an associate editor of the Journal of Materials Chemistry B. Professor Chang has over 290 scientific papers published in international peer-reviewed scientific journals and holds over 30 issued patents in the field of biomedical materials.

Page 13: List of Confirmed Keynote Speakers

Tze-Wen Chung, Ph.D.

Professor of the Dept. of Biomedical Engineering National Yang-Ming University Taipei, Taiwan, ROC.

Email:[email protected]

Biography

T.W. Chung is the professor of the Dept. of Biomedical Engineering, National Yang-Ming Univ., Taiwan, ROC. He received PhD in Chemical and Materials Engineering in the University of Oklahoma. His researches are focus in biomaterials and regenerative medicine. He grafted RGD and other ligands to biomaterials with varying nano-roughness for promoting proliferations of various cells such as HUVEC and PC12 cells. He developed a silk fibroin- hyaluronic acid (SF/HA)/bone marrow stem cells (BMSC) cardiac patches for cardiac repairs. The hybrid patches were demonstrated by good BMSC cardiomyogenesis in-vitro, and improving LV remodeling and cardiac functions in both a rat and pig MI heart models. He has published 80 peer-reviewed papers. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and will be inducted a Fellow of International Union of Societies for Biomaterials Science and Engineering (IUSBSE) in 2016. He also received other Awards in Taiwan.

Page 14: List of Confirmed Keynote Speakers

Simon Cool Senior Principal Investigator and Professor (Adjunct Research), Institute of Medical Biology, Agency for Science, Technology and Research Singapore

Biography

Dr Cool began his scientific career at the University of Queensland in Brisbane, Australia over 20 years ago. He received his BSc (hons) and PhD degrees from the University of Queensland, where he subsequently held a faculty position in the School of Biomedical Sciences. His areas of studies have included age-related changes in the structure of bone and teeth and the extracellular matrix compartment of skeletal tissue that guide stem cell behavior and wound repair. Dr Cool was invited to join the Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore in 2003 as a principal investigator. He then joined A*STAR’s Institute of Medical Biology in 2008, shortly after its inception, to further his research in regenerative medicine. Currently, as Senior Principal Investigator of the Glycotherapeutics Group, Dr Cool is focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity. Most particularly, he has developed glycotherapeutic compounds and adult stem cell-based therapies for the treatment of bone and cartilage injury, cardiovascular disease, and skin wounds. Dr Cool has over 54 granted patents in the field of glycosaminoglycan biochemistry, regenerative medicine and stem cell science and more than 95 research publications and continues to foster strong strategic collaborations both nationally and internationally with academic and industry groups. Dr Cool is an Adjunct Professor (Research) in the Orthopaedic Department at the National University of Singapore. Dr Cool is currently an elected member of the Council for the Tissue Engineering and Regenerative Medicine International Society, Asia Pacific Chapter. He is an executive editor for the journal Gene, section editor for the Journal of Molecular Histology, and serves on the Editorial Boards of Biomaterials and Stem Cells and Development.

Page 15: List of Confirmed Keynote Speakers

Ranieri Cancedda Professor of Cell Biology at the University of Genova. Head of the Laboratory of Regenerative Medicine of the IRCCS AOU San Martino-IST National Cancer Research Institute, Genova, Italy

Biography

Dr. Ranieri Cancedda is a Professor of Cell Biology and Dean of the Biotechnology School and Coordinator of the PhD program in Biotechnology in Translational Medicine at the University of Genova, Italy. He also serves as Head of the Laboratory of Regenerative Medicine (Cell Differentiation) of the San Martino-IST National Cancer Research Institute, Genova. Prior to this he was the Chairman of the Department of Innovative Therapies, National Cancer Research Institute, Genova.

Dr. Cancedda graduated magna cum laude from the University of Genova, Italy, where he earned his MD degree. He then won a fellowship to Nigeria at the University of Ibadan, Department of Hematology. He also did postdoctoral work as a Research Associate in the Department of Microbiology, Washington University School of Medicine in St. Louis, Missouri, and was a Visiting Professor at the Roche Institute of Molecular Biology, Nutley, New Jersey. He served as professor of General Biology and Chairman of the Department of Cellular and Molecular Biochemistry at the second Medical School, Naples, Italy.

Dr. Cancedda has spent most of his professional career in studying and developing methods of tissue reconstruction using stem cells, biomaterials, and active biomolecules such as growth factors and angiogenic molecules and is considered in academic circles as one of the forefathers of tissue engineering. He has been invited as keynote speaker and lecturer at many international congress and meetings, is the author of more than 300 publications in scientific journals (H-index 71; citations >19,000), and inventor in 7 patents.

He is one of the founders and the first President of the European Tissue Engineering Society, which is now the European Chapter of the Tissue Engineering and Regenerative Medicine International Society (TERMIS). Dr. Cancedda is currently a Fellow of TERMIS.

Dr. Cancedda is Chief Editor of Frontiers in Bioengineering and Biotechnology, specialty: regenerative medicine and tissue engineering (Nature group) and serves as an Editorial Board Member of several peer-review journals, such as Tissue Engineering, Journal of Tissue Engineering and Regenerative Medicine, and European Journal of Cell Biology.

Page 16: List of Confirmed Keynote Speakers

I-Ming Chu, Ph.D. Professor, National Tsing Hua University Email: [email protected] Hsinchu, TAIWAN

Biography I-Ming Chu is currently Professor of Chemical Engineering at National Tsing Hua University in

Hsinchu, Taiwan. He was the President of Biotechnology and Biochemical Engineering Society of Taiwan, 2008-2011 and President of Biomaterials and Controlled Release Society in Taiwan, 2002-2004. He was the director of Bioengineering Research Center of National Tsing Hua University, 2000-2007 and served as chairman of Graduate School of Biotechnology and Bioengineering at Yuan Ze University, Taoyuan, Taiwan, 2009-2012.

He studied various polymeric micelles and thermosensitive hydrogels used in tissue engineering and drug delivery. Those materials have been applied to bone and cartilage regeneration and bone substitutes.

He has authored over 130 academic papers and 11 patents in biotechnology and biomaterials. He was recognized by many awards from academic societies and is a fellow of Federation. of International Societies for Biomaterials Sciences and Engineering.

Page 17: List of Confirmed Keynote Speakers

Win-Ping Deng, Ph.D Distinguished University Professor Director, Stem Cell Research Center Taipei Medical University Chair Professor Fu Jen Catholic University Editor, Biomaterials (IF=8.35) Distinguished Alumni, National Tsing Hua University (2012) General Secretary Taiwanese Society for Molecular Imaging (TSMI)

Biography Professor Deng obtained his doctorate in cancer biology at the Harvard University in 1993. Dr. Deng then joined the postdoctoral training at Jac A. Nickoloff ’s lab where he directed research of preferential repair of UV damage in highly transcribed DNA and research of mismatch repair of heteroduplex DNA intermediates of extrachromosomal recombination in mammalian cells. This led to the development of powerful genetic recombination analysis and gene therapy in mammalian cells. In 2000, Dr. Deng joined the faculty of the Collage of Oral Medicine at the Taipei Medical University where now he is the Distinguished University Professor and Director of Stem Cell Center. Dr. Deng pioneered a new research for combining stem cell and molecular imaging to study the cancer therapy and tissue regeneration

Page 18: List of Confirmed Keynote Speakers

Greg Dusting Executive Director Research Professorial Fellow and Principal Research Fellow, Centre for Eye Research Australia, University of Melbourne Australia

Biography

Greg is a Principal Research Fellow of the National Health & Medical Research Council and a Professor of Pharmacology and Surgery at the University of Melbourne. Over 30 years he has published more than 220 papers which have attracted over 5000 citations in medical and scientific literature. Greg’s Cytoprotection Pharmacology team is discovering new ways to protect cells and tissues from injury or death caused by disease or trauma, or indeed in applying stem cell technology in regenerative medicine. He is at the forefront of research in the field of NADPH oxidase signaling, has made major contributions to elucidating its roles in oxidative stress in vascular disease and reperfusion injury, and has discovered two classes of compounds that inhibit its activity.

Page 19: List of Confirmed Keynote Speakers

Mime Egami Chief Medical Innovation Officer, Visiting Professor Institute of Advanced Biomedical Engineering & Science Tokyo Women's Medical University Tokyo, JAPAN

Biography

Career History: 1981 March : International Finance & Economy, Hitotsubashi University 1981 April -1996 January: Financial Products and Corporate Finance at Mitsubishi Bank and other foreign banks in Tokyo 1996 February - 1998 November: President of Welltime Inc. (Alliance Advisory for Pharma & Biotech companies) 1998 November - 2005 November: Director and Head of Healthcare & Life Science Advisory, ABN AMRO Bank Tokyo 2005 November - : Strategy Advisor, TUBERO(SCOE), Tohoku University (-2009) Visiting Professor, Tokyo Women's Medical University (2007- Present)

Other Activities: New Energy and Industrial Technology Development Organization(NEDO) Auditor Japan Science Technology Agency (JST), Intellectual Property Strategy Committee Japan Society of Regenerative Medicine, Industry Promotion Committee Tissue Engineering Regenerative Medicine International Society (Asia Pacific), Treasurer Engineering Academy of Japan, Policy Committee

Regulatory Affairs Professionals Society (RAPS) Japan, Chief Representative

Page 20: List of Confirmed Keynote Speakers

John Fisher University of Maryland U.S.A

Biography

Dr. John P. Fisher is Fischell Family Distinguished Professor and Associate Chair for Graduate Studies in the Fischell Department of Bioengineering at the University of Maryland. Dr. Fisher is the Director of the Tissue Engineering and Biomaterials Laboratory and investigates biomaterials, 3D printing, stem cells, and bioreactors for the regeneration of lost tissues, particularly bone, cartilage, vasculature, and skeletal muscle. Key recent developments include the creation of a modular and scalable bioreactor for cell and tissue culture as well as the fabrication of 3D printed substrates for tissue regeneration. The lab is supported by research grants from NIH, FDA, NSF, DoD, and other institutions, and has authored over 100 publications, 230 scientific presentations, and 12 patents / patent applications. In 2012 Dr. Fisher was elected Fellow of the American Institute for Medical and Biological Engineering. Dr. Fisher is currently the Editor-in-Chief of the journal Tissue Engineering, Part B: Reviews, and Continental Chair Elect of the Tissue Engineering and Regenerative Medicine Society International - Americas Chapter.

Page 21: List of Confirmed Keynote Speakers

Xiaosong Gu Nantong University China

Biography

Professor Xiaosong Gu, M.D., is Director of Jiangsu KeyLajborajtory of Neuroregeneration of Nantong University, Honorary President of Chinese Society for Anatomical Sciences (CSAS) and the chief of Regenerative Medicine Branch of CSAS, the chief of Development and Regeneration Branch of Chinese Neuroscience Society (CNS). Prof. Gu works as the editor-in-chief of Medical Journal of Communications, associate editor-in-chief of Current Stem Cell Research & Therapy, and the editorial board member of Biomaterials, Cell Transplantation: The Regenerative Medicine Journal, Neuroscience Bulletin, and Neural Regeneration Research. Prof. Gu focuses his research on tissue engineered nerve and the molecular mechanisms underlying neural regeneration. So far, he has published 112 academic articles in SCI-indexed journals such as Brain, Biomaterials, Nucleic Acids Research, Progress in Neurobiology, Cell Reports, Journal of Cell Science, Nature Cell Biology, and Stem Cell. As one of the main inventors, he has been granted several Chinese and international patents.

Page 22: List of Confirmed Keynote Speakers

Zhongwei Gu Sichuan University China

Biography

Professor Zhongwei Gu received his B. Sci. and M. Sci in Polymer Science from Peking University, prior to serving as a senior visiting scholar in the Research Triangle Institute, RTP and the University of Utah, respectively from 1984 to 1986 and 1991 to 1993. He was appointed as a professor in 1994, and has thrice being the chief scientist of the National Basic Research Program of China (the 973 program) since 1999, vice-chairman of the Chinese Society for Biomaterials (CSBM), executive member of the council of the Chinese Materials Research Society (C-MRS) and Chinese Society for Biomedical Engineering (CSBME) and is a Fellow of international Biomaterials Science and Engineering(FBSE). His current research activities focus on the controlled preparation of novel biomedical polymers, self-assembled nano-biomaterials, controlled drug/gene delivery systems, and biomaterials for molecular diagnosis. He has published more than 280 papers and received ~25 patents, composes/translates ~14 books and chapters, and is the invited speaker in many international and domestic conferences.

Page 23: List of Confirmed Keynote Speakers

May Griffith Professor of Department of Clinical and Experimental Medicine Professor of Regenerative Medicine Linköping University Linköping, Sweden.

Biography

May Griffith is Professor of Regenerative Medicine at Linköping University, Sweden. She received her PhD from the University of Toronto. After serving as faculty at the University of Ottawa for over 15 years, she moved to Linköping University, Sweden to focus on translational regenerative medicine. Her group works on biomaterials enhanced or enabled cell-based regeneration. She has been focusing mainly on corneal regeneration. Together with her clinical collaborators, she has completed a Phase I clinical study where cell-free biomimetic scaffolds implanted enabled regeneration of human corneas that normally on their own, do not regenerate. A multi-centre Swedish trial is now being planned for a second generation implant that has shown promise for patients at high risk for rejection of conventional donor cornea implants. Prof. Griffith's biosynthetic - and also biomimetic - materials have also been successfully tested in collaboration with other researchers for use in cartilage and cardiovascular regeneration. In 2013, Prof. Griffith led her EU Nanomedicine team on the project, "I-CARE" to win the ETPN nano medicine award for regenerative medicine. One of the implants optimised in I-CARE is now being tested in pre-clinical large animal trials and human clinical trials.

Page 24: List of Confirmed Keynote Speakers

James Goh Professor & Head, Department of Biomedical Engineering Research Professor, Department of Orthopaedic Surgery National University of Singapore President

International Federation of Medical and Biological EngineeringSingapore

Biography

James GOH obtained his BSc (1st Class Honours) in Mechanical Engineering (1978) and PhD in Bioengineering in 1982 from the University of Strathclyde, Glasgow, UK. He is currently Professor and Head, Department of Biomedical Engineering, Faculty of Engineering, NUS and holds a joint appointment, as the Research Professor in the Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, NUS. He is also Director, Centre for Healthcare Innovation and Medical Engineering (CHIME). Prof Goh is on a number of national as well as international committees. He chairs the Science and Technology Advisory Board of the Singapore Sports Institute. He is the President of the Biomedical Engineering Society (Singapore) and the President of the International Federation of Medical and Biological Engineering. Prof Goh has been actively involved in organizing international conferences and had served on numerous International Scientific Committees. He chaired the 6th World Congress of Biomechanics, (2010), TERMIS-AP (2011) and 15th ICBME (2013). Prof Goh has an active research interest in musculoskeletal research and advances in biomedical engineering. He has given numerous invited talks at international and regional conferences. He has published well over 130 international peer review journal papers, more than 500 conference papers and 12 book chapters.

Page 25: List of Confirmed Keynote Speakers

Zigang GE, M.B.B.S., Ph.D. Professor, Peking University Email: [email protected]

Beijng, P.R.China

Biography

Dr. GE took a faculty position in 2007 at Peking University, where he is currently a professor of Biomedical Engineering and adjunct Professor of Center for Joint Disease, Peking University Renmin Hospital and serves as Director of Cartilage Laboratory. His lab focuses on regenerative biology and medicine of articular cartilage. He has co-authored ~50 peer reviewed papers and book chapters and given dozens of invited talks. His work has been recognized with the 2006 Singapore Millennium Scholar and currently serves in multiples committees at both China and worldwide. The MOST, NSFC, Novo Nordisk have supported his lab’s research.

Page 26: List of Confirmed Keynote Speakers

Changyou Gao, Ph.D. Prof. and Associate Chair of Department of Polymer Science and Engineering Director of Institute of Biomedical Macromolecules Zhejiang University Hangzhou 310027, China

Biography

Changyou Gao received his Ph.D. (1996) in the field of polymer chemistry and physics from Jilin University. He worked in the Department of Polymer Science and Engineering of Zhejiang University as a postdoctoral fellow from 1996 to 1998, before joining the faculty as an associate professor from 1998 to 2001 and as a full professor since 2002. He was a principal investigator for the National Science Fund for Distinguished Young Scholars of China (2004), and was appointed as a Changjiang Scholar by the Ministry of Education (2007). His research interests are biomedical materials for tissue engineering and regenerative medicine, and colloids and nano-biomaterials for drug delivery and cellular interaction. He has published over 200 peer-reviewed articles and reviews with an H-index of 50. Currently he serves as an editorial board member of Journal of Zhejiang University Part A, Science China Chemistry, Progress in Chemistry, Chinese Journal of Polymer Science, and Colloids and Surfaces B: Biointerfaces.

Page 27: List of Confirmed Keynote Speakers

Akon Higuchi, Ph.D. Chair Professor, National Central University Visiting Professor, King Saud University Email: [email protected] Jhong-li, TAIWAN

Biography

Akon Higuchi is currently Professor at National Central University (NCU) in Jhongli, Taiwan and Visiting Professor at King Saud University, Riyadh, Saudi Arabia. He received Sofue Memorial Award from Society of Fiber Science, Japan in 1994, Seikei Academic Award from Seikei Alumni Association in 2003, and Nanotechnology Outsatnding Contribution Award, National Science Council, Taiwan in 2013 and Fellow of Royal Society of Chemistry in 2014. He is an Advisory Board of Journal of Materials Chemistry B (RSC) and an Editor-in-Chief of Am. J. Tissue Eng. & Stem Cell. He is interested in the development of biomaterials for stem cell research. He established purification method of hematopoietic stem cells and mesenchymal stem cells from umbilical cord blood and adipose tissue, respectively by filtration method through polymeric porous membranes. He is also developing biomaterials for stem cell culture and differentiation. He published three articles in Chemical Reviews (Impact factor=46.6) and two articles in Progress in Polymer Science (Impact factor=26.9).

Page 28: List of Confirmed Keynote Speakers

Nathaniel Hwang, Ph.D. Associate Professor, Seoul National University Email: [email protected] Seoul, Republic of Korea

Biography

Nathaniel S. Hwang is currently an Associate Professor in the School of Chemical and Biological Engineering at Seoul National University, Republic of Korea. He is also a member of Institute for Chemical Processes at Seoul National University, and he also holds appointments from Interdisciplinary Program in Bioengineering and Stem Cell Graduate Program at the Seoul National University, Republic of Korea. Dr. Hwang received a bachelor degree in Biomedical Engineering from Johns Hopkins University Whiting School of Engineering in 2002. He obtained his Ph.D. in Biomedical Engineering from the Johns Hopkins School of Medicine in 2007 under the guidance of Professor Jennifer Elisseeff. After doctoral studies, he was a visiting scholar at the University of California, San Diego, Department of Bioengineering, and worked with Professor Shyni Varghese. From 2008 through 2011, he worked as a postdoctoral associate in Professor Robert Langer’s laboratory at Massachusetts Institute of Technology. In 2011, Dr. Hwang joined the School of Chemical and Biological Engineering at Seoul National University. Dr. Hwang is currently leading a group of students that work together to develop new biomaterials, study stem cells, and design new technologies for regenerative medicine. He has published over 56 research articles and book chapters covering biomaterials and stem cells for musculoskeletal tissue regeneration.

Page 29: List of Confirmed Keynote Speakers

Yu-Chen Hu, Ph.D. Program Chair, TERMIS-AP 2016 meeting Fellow, American Institute for Medical and Biological Engineering (AIMBE) Distinguished Professor and Chairman Department of Chemical Engineering, National Tsing Hua University

Hsinchu, Taiwan.

Biography

Dr. Yu-Chen Hu received his BS degree in Chemical Engineering from National Taiwan University (1992) and earned his PhD degree in Chemical Engineering from University of Maryland (USA) in 1999. He worked as a post-doc at the National Institutes of Health from 1999 to 2000 and returned to the Department of Chemical Engineering, National Tsing Hua University, Taiwan, in 2000. Dr. Hu’s main research interests include vaccine development, gene therapy, tissue engineering, cancer therapy and synthetic biology. Dr. Hu's lab has developed the enterovirus 71 (EV71) vaccine based on virus-like particle technology and avian influenza vaccine based on baculovirus vector. Dr. Hu also utilizes baculovirus as a gene vector to deliver various genes encoding growth factor or microRNA into adult stem cells/cell sheet for the modulation of cellular differentiation states and tissue regeneration. His recent animal studies have demonstrated that the baculovirus-engineered cells, after implantation into animals, repair massive defects in cartilage and bone. Dr. Hu’s lab also exploits baculovirus-engineered stem cell sheet for the management of myocardial infarction and bone infection. Dr. Hu’s works have a new avenue to the use of baculovirus as a novel vector for regenerative medicine. Dr. Hu has won the Asia Research Award (Society of Chemical Engineers, Japan), Outstanding Research Award (Ministry of Science and Technology, 2006, 2014), BEST Biochemical Engineering Achievement Award, Wu Ta-You Memorial Award (NSC), Outstanding Academia-Industry Research Award and Outstanding Young Investigator Award in Taiwan. He is inducted as a fellow of American Institute for Medical and Biological Engineering (AIMBE), and is elected the Member of the Tissue Engineering International & Regenerative Medicine Society-Asia Pacific (TERMIS-AP) Council. He is the Program Chair of the TERMIS-AP meeting, 2016. He also sits on the editorial board of 10 international journals and currently serves as the associated editor of Current Gene Therapy and deputy editor of Journal of Taiwan Institute of Chemical Engineers.

Page 30: List of Confirmed Keynote Speakers

Jöns Hilborn

Head of Polymer Chemistry, Uppsala University, Sweden President of Tissue Engineering & Regenerative Medicine International Society (TERMIS) Materials Chemistry, Uppsala University, 751 21 Uppsala, Sweden

Biography

Jöns Hilborn is since 2001 the head of the Polymer Chemistry program at the Department of Materials Chemistry, Uppsala University in Sweden. He has extensive management experience from life science industry and co-ordination of European projects. His research interests are in the design, synthesis and preparation of polymers and specifically materials for tissue scaffolds and as delivery vehicles. Current focus is on injectable in-vivo gel forming matrices that acts on endogenous cells to regenerate and the development of RNAi to allow translation to therapies. Chemistry, biology, engineering is combined with medicine to bring basic research findings from the lab bench to the clinic and commercial applications. He served as president of “Tissue Engineering and Regenerative Medicine International Society” (TERMIS), which he was a part of creating. He currently serves as ERC panel chair, board member of the UK medical research council in regenerative medicine, associate editor, international advisor and the editorial board for a number of journals. He received his PhD from the Royal Institute of Technology in Stockholm, which was followed by seven years in industry before he joined the Swiss Federal Institute of Technology in Switzerland for eight years. He is a frequently invited speaker at international events and has published 350 scientific papers (h=42), 26 patents and has started 7 companies.

Page 31: List of Confirmed Keynote Speakers

Patrick C.H. Hsieh, M.D., Ph.D. Research Fellow and Professor Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan

Biography

Dr. Patrick Hsieh received his MD degree from Kaohsiung Medical College, Taiwan, in 1992, completed his clinical training in cardiovascular surgery from National Taiwan University Hospital in 1999, received a PhD degree from Department of Bioengineering, University of Washington, Seattle, in 2003, and finished his postdoctoral fellowship at Harvard Medical School and MIT in 2006. Since back to Taiwan, Dr. Hsieh focuses his research on cardiac regeneration using stem cells, nanotechnology, drug/gene delivery, and tissue engineering. He has received several awards including National Innovation Awards, and National Science Council Outstanding Research Award. He was elected to International Fellow of American Heart Association, and was recognized as a top translational researcher in 2012 by the Nature Biotechnology journal. Dr. Hsieh has published more than 50 scientific papers including those in Nature Medicine, Science Translational Medicine, Journal of Clinical Investigation, Circulation, PNAS and ACS Nano. He has filed more than 12 international patents, and has applied his research results into clinical therapy for cardiovascular regenerative medicine.

Page 32: List of Confirmed Keynote Speakers

Gun-Il Im Dongguk University Ilsan Hospital, Goyang, Republic of Korea Korea

Biography

Dr. Gun-Il Im, M.D., Ph.D is currently Professor in Department of Orthopaedics and Dean of Planning, Dongguk University Medical Center, Korea. He is a Steering Committee Member in International Combined Orthopaedic Research Society, Member at Large of Osteoarthritis Research Society International, Council Member of Tissue Engineering and Regenerative Medicine International Society Asia-Pacific Chapter. He is also an Associated Editor of Tissue Engineering and Regenerative Medicine, and Editorial Board Member of Journal of Orthopaedic Research, Hip and Pelvis, and Clinics-in-Orthopaedics. His other current academic positions include Vice President of Korean Tissue Engineering and Regenerative Medicine Society, Vice President of Korean Society for Biomaterials, Chairman of Planning Committee in Korean Society for Bone and Mineral Research, Chairman of Scientific Committee of Korean Orthopaedic Research Society, and Council Member of Korean College of Rheumatology. Dr. Im has been working on the field of stem cell and tissue regeneration of musculoskeletal system since 1996. He has published 101 peer-reviewed scientific papers in international journals and holds 12 national and international patents. He has been performing multidisciplinary research in cooperation with scientist and engineers of various fields to translate the research product into clinical application.

Page 33: List of Confirmed Keynote Speakers

Yoshihiro Ito Chief Scientist and Director, Nano Medical Engineering Laboratory Japan

Biography

Yoshihiro Ito is a Chief Scientist and Director of Nano Medical Engineering Laboratory at RIKEN and a Team Leader of Emergent Bioengineering Materials Research Team at RIKEN Center for Emergent Matter Science. He received his doctoral degree from Graduate School of Polymer Chemistry, Kyoto University in January 1987. His research interests are molecular evolutionary engineering, nano-biomaterials, and tissue engineering. Professor Ito has received numerous awards such as The Award of Japanese Society of Biomaterials, Fellow of International Union of Societies for Biomaterials Science and Engineering, and Significant Achievement Award RIKEN.

Page 34: List of Confirmed Keynote Speakers

Kazunori Kataoka The University of Tokyo Japan

Biography

Kazunori Kataoka, Ph.D. is Professor of Biomaterials at Graduate School of Engineering, the University

of Tokyo, Japan. He has been appointed joint position since 2004 from Graduate School of Medicine, the University of Tokyo as Professor of Clinical Biotechnology at Center of Disease Biology and Integrative Medicine. Dr. Kataoka received several awards, including the Society Award from the Society of Polymer Science, Japan (2000), Clemson Award from the Society for Biomaterials USA (2005), Founder’s Award from the Controlled Release Society (2008), Humboldt Research Award (2012), Leo Esaki Prize (2012), and Gutenberg Research Award (2015). He served as the president of Controlled Release Society (2012-13). His current major research interest is supramolecular materials for nanobiotechnology, particularly focusing on drug and gene targeting, and has published more than 500 papers with high citations as selected as “Highly-Cited Researchers” by Thomson Reuters.

Page 35: List of Confirmed Keynote Speakers

Deling Kong, Ph.D. Professor of Biological Chemistry, College of Life Science, Nankai University; Professor of Institute of Biomedical Engineering, Chinese Academy of Medical Sciences. Nankai District, Tianjin China

Biography

Dr. Kong is a Professor of Biological Chemistry, Director of the Key Laboratory of Bioactive Materials,

Ministry of education at Nankai University. His research interests focus on cardiovascular regenerative medicine, including stem cell treatment of myocardium infarction and vascular grafts. In stem cell therapy, his group use bioactive hydrogel to improve the survival of the implanted stem cells and regulate their differentiation and paracrine. They also use the molecular imaging technology to track the implanted cells and study the function mechanism. Their work in vascular grafts focuses on creation of multifunctional and bioactive scaffolds with ideal material properties that can facilitate rapid endothelialization, regeneration of functional smooth muscle layer, and maintain long-term patency. Dr. Kong won the Outstanding Youth Fund of NSFC in 2007. He won the 2nd class National Scientific Technology Progress Award of China in 2009, and the 2nd class Natural Science Award of Tianjin in 2010. He has published more than 150 peer reviewed papers, which were cited over 3000 times. He is also holding more than 15 approved patents..

Page 36: List of Confirmed Keynote Speakers

Shinji Kamakura Tohoku University Japan

Biography

D.D.S. in 1983 in Tohoku University School of Dentistry, Sendai, Japan. Ph.D. in 1987 in Tohoku University Graduate School of Dentistry. Resident at Sendai National Hospital, Oral and Maxillofacial Surgery, Sendai, Japan (1987~1990). Assistant Professor at Department of Maxillofacial Surgery I, Tohoku University School of Dentistry (1990~2002). Visiting Scholar at University of Iowa, Department of Hospital Dentistry, Division of Oral and Maxillofacial Surgery, IA, USA (1999~2000). Associate Professor at Division of Clinical Cell Therapy, Tohoku University School of Medicine (2002~2008). Professor at Bone Regenerative Engineering Laboratory, Regenerative and Biomedical Engineering Division, Graduate School of Biomedical Engineering, Tohoku University (since 2008). My main research focuses on bone regeneration by octacalcium phosphate collagen composite (OCP/Collagen) which is made by granules of synthetic octacalcium phosphate and medical-grade collagen. Through the various safety tests and preclinical animal study, sponsor-initiated clinical trials have recently begun to aim for commercialization as a new bone regenerative material in oral and maxillofacial surgery.

Page 37: List of Confirmed Keynote Speakers

Moon Suk Kim, Ph.D. Professor, Ajou University Email: [email protected]

Suwon, Korea

Biography

Dr. Moon Suk Kim is the Professor of Department of Molecular Science and Technology at Ajou University in South Korea. He is also Adjunct Professor of Purdue University, U.S.A. He served as a Principal Research Scientist in Nanobio-Fusion Research Center, Korea Research Institute of Chemical Technology from 2003-2009. He moved to Ajou University in 2009 to focus on development of biomaterials as drug, cell and gene carriers for tissue engineering and regenerative Medicine.

He is a member of the Korea Tissue Engineering and Regenerative Medicine Society. Moreover, from 2015 to the present, he serves as a TERMIS-AP Council Members. He has published ~170 peer-reviewed research manuscripts, ~20 book chapters and holds more than 27 issued patents. His work has been recognized by Excellence Research Achievement Award of the Korea Research Institute of Chemical Technology, Ajou Excellence Achievement Award of the Ajou University, and Medi-Post Distinguished Scientist Award of the Korea Tissue Engineering and Regenerative Medicine Society.

Page 38: List of Confirmed Keynote Speakers

Byung-Soo Kim, Ph.D. Professor, Seoul National University

Seoul, Korea Email: [email protected] Webpage: http://scte.snu.ac.kr

Biography

Byung-Soo Kim is a Full Professor of Chemical and Biological Engineering in Seoul National University, South Korea. He received his B.S. (1990) and M.S. (1992) degrees from Seoul National University and Ph.D. degree (1999) from University of Michigan. His research focuses on developing therapies by combining stem cells and biomaterials. He is an active researcher with 290 peer-reviewed publications, 14 book chapters, and 19 patents. He has received William B. Walsh Award and Shinyang Award. He had served or now serves as Associate Editor or editorial board member of more than 10 journals, Scientific Director of Korean Tissue Engineering and Regenerative Medicine Society, Associate Member of the Korean Academy of Science and Technology, and the TERMIS-AP Council member

Page 39: List of Confirmed Keynote Speakers

Masahiro Kino-Oka Department of Biotechnology Osaka University

Biography

Masa (Masahiro KINO-OKA) is one of leaders in the field of manufacturing for cell and tissue products; individuals who seem able to contribute to the standardization of the cell processing facility and bioreactor. His current research interests are “Bioprocess engineering” to establish the cell and tissue manufacturing system including the fields of “Bioreaction Engineering”, “Bioprocess design”, and “Stem Cell Engineering”. Masahiro KINO-OKA earned his B.S. in Department of Chemical Engineering at Osaka University in 1989, and M.S. in 1991. He became the research assistant, Department of Chemical Engineering, Osaka University (1991-2000), having the project of bioreactor and process design for plant tissue culture. After getting the Ph.D. in 1996, he spent one year as a visiting staff in the Department of Chemical Engineering, National Institute of Switzerland (ETH) in Zurich and started the new project for bioreactor design for human cells toward clinical application. After returning Japan (1997), he promoted twice in his five-year tenure (Assistant Professor, Department of Chemical Engineering, Osaka University (2000), Associate Professor, Department of Chemical Engineering, Osaka University (2003), and finally three years ago (2009) he earned a current position of Professor in Biotechnology, Osaka University. Prior to Department of Biotechnology, Kino-oka had many experiences for bioreactor and process designs for human cell culture toward clinical application. Now he starts new projects for manufacturing including facility design of cell and tissue processing. To develop the facility, he has joined to ISO to be international member in ISO TC198 / WG9 for aseptic processing.

Page 40: List of Confirmed Keynote Speakers

Subhas C. Kundu Indian Institute of Technology Kharagpur India

Biography

Subhas C Kundu, Ph. D. is Professor (Re-employed) at the Department of Biotechnology of Indian Institute of Technology, Kharagpur. Dr. Kundu received his post-doctoral training at Institute of Molecular Biology, Moscow; Department of Biology, York University, Canada; Medical University, Lubeck, Germany; Department of Biology & Biochemistry, Brunel University, UK. His main research interest at present is in nonmulberry silk materials for regenerative medicine. He has published 80 research articles on silk materials. He is also associated with a few national and international research projects. He is a Fellow of the National Academy of Sciences, India.

Page 41: List of Confirmed Keynote Speakers

Gang Li Professor, Department of Orthopaedics & Traumatology Faculty of Medicine, The Chinese University of Hong Kong Hong Kong

Biography

Dr. Gang Li is Professor in the Department of Orthopedics and Traumatology and Deputy Chief of the Stem Cell and Regeneration Program, School of Biomedical Sciences, and, Faculty of Medicine at the Chinese University of Hong Kong. Previous to this appointment, he was Senior Lecturer and Reader, School of Medicine, Queen’s University, Belfast, UK. Dr. Li earned an MBBS at the Fourth Military Medical University, Xian, China, and a D. Phil at the University of Oxford School of Medicine, England, UK. The focus of his research at Oxford was on studies of the biological mechanisms of distraction osteogenesis. Other areas of research interests currently include stem cell biology and cell culture techniques, circulating MSCs, stem cell gene therapy, the use of MSCs as anti-cancer vehicles, cell therapy applications, musculoskeletal tissue regeneration, and fracture repair. He has published more than 120 peer-reviewed SCI articles with citations over 4000 and H index 28; 15 book chapters, edited 3 books on tissue engineering, distraction histogenesis, leg-lengthening and Ilizarov techniques. He served as Honorary Treasurer of British Orthopaedic Research Society (2004-2006), Member of Programe Committee of American Orthopaedic Research Society (2006-2007) and currently is the general secretary of Limb Reconstruction society, Chinese Association of Orthopaedic Surgeons. Prof, Li is a council member of Chinese Orthopaedic Research Society, Chinese Medical Association; council member of Tissue Engineering and Regenerative Medicine Society, Chinese Association of Biomedical Engineering. Prof. Li holds honorary Professorship at Sichuan University, China; Shanxi Medical University, China; China Medical University; South-East University Medical School, China; The Forth Military Medical University, China; Guangdong Medical College, China.

Page 42: List of Confirmed Keynote Speakers

Il Woo Lee Professor of Neurosurgery Catholic University of Korea Seoul, Korea

Biography Il Woo Lee is a Neurosurgeon and Professor of Neurosurgery at Catholic University of Korea. He received his PhD from the Department of Neurosurgery Catholic University of Korea and have been serving as Professor of Neurosurgery at same University. He spent 2 years abroad as research fellow at Brigham and Women’s and Children's Hospital at Harvard Medical School, Boston, USA under the guidance of Professor R. Michael Scott and Joseph R. Madsen (Neurosurgery) and Joseph P. Vacanti (Tissue Engineering) from March 1996 to Jan 1998 and worked as visiting professor at Department of Neurosurgery and Stem cells Laboratory at Stanford University Medical Center from June to Aug, 2006. He served as president of The Korean Society of Pediatric Neurosurgery (2008-2009) and the president of Korean Tissue Engineering and Regenerative Medicine Society (2011-2012). Also he served as a chairman of scientific committee, 2nd World Congress of Tissue Engineering and Regenerative Medicine at Seoul, Korea (2009) and associate editor of Korean Journal of Pediatric Neurosurgery, Biomaterial Research and Tissue Engineering and Regenerative Medicine. His major scientific interests focused on Pediatric Neurosurgery and Regeneration of Central and Peripheral Nervous system using tissue engineering technique with biomaterials and stem cells. He has published 11 book chapters and many articles about Neurosurgery, Tissue Engineering and Regenerative Medicine.

Page 43: List of Confirmed Keynote Speakers

Doo Sung Lee Director, Theranostic Macromolecules Research Center (NRF) Professor, School of Chemical Engineering, SungKyunKwan University,

Biography Doo Sung Lee received his B.S. (1978) in Chemical Engineering from Seoul National University. Then

he obtained his M.Sc. (1981) and PhD (1984) in Chemical Engineering from Korea Advanced Institute of Science and Technology (KAIST). He stared his professional career in Sungkyunkwan University of Korea since 1984. He was working as President of Polymer Society of Korea (2013-2015). He became Director of Theranostic Macromolecules Research Center (National Engineering Research Center) in 2010. He is now Member of The Korean Academy of Science and Technology and Member of National Academy of Engineering of Korea. He is also working as Editorial Board Member of several international journals (Nanomedicine, Advanced Healthcare Materials and Biomaterials Science). His research interest is stimuli-responsive polymeric nanoparticles for biomedical applications and injectable hydrogels for drug/protein/gene release and tissue engineering. So far, he has published 164 peer-reviewed papers and issued 27 international patents.

Page 44: List of Confirmed Keynote Speakers

Hai Bang Lee, Ph.D. Email: [email protected]/ [email protected]

Biography Hai Bang Lee is a Research Professor of Ajou University, Department of Molecular Science and Technology and an Emeritus Scientist and Consultant of Korea Research Institute of Chemical Technology. He received his PhD degree with Biomaterials Research in the Department of Materials Science and Engineering at the University of Utah in 1974. He worked dental polymer as research associate at Dental Research Center, University of North Carolina at Chapel Hill from 1974 to 1976. He also worked in ophthalmic, orthopedic and medical disposable products development for U.S. Biomedical Industries, from 1976 to 1984 and joined Korea Research Institute of Chemical Technology for research in the area of biomaterials, drug delivery and tissue engineering as the Director and Distinguished Scientist of Biomedical Polymer Research Laboratory from 1984 to 2009. He has more than 390 publications, filed 104 patents, and numerous conference presentations including plenary/keynote/invited lectures. Dr. Lee devoted so much to the initial establishment stage of Tissue Engineering Society International (TESi) and Tissue Engineering and Regenerative Medicine International Society (TERMIS), as well as throughout the promotion of research in Asia-Pacific region. He served as the first vice president of TESi for the AP region, 2003~2005, and the first TERMIS-AP Chapter Chair, 2005~2008. He also served as the first President of the Korean Tissue Engineering & Regenerative Medicine Society (KTERMS), 1999~2004. He has received awards as the Presidential Award of Korea Science & Technology in 1994 (the highest ward in science & technology on Korea), National Order of Civil Merit in 1989, Fellow of the American Institute for Medical and Biological Engineering, Fellow of the International Union of Societies for Biomaterials Science and Engineering, Fellow of Regenerative Medicine, and member of Korean Academy of Science & Technology.

Page 45: List of Confirmed Keynote Speakers

Jin Ho LEE, Ph.D.

Professor, Hannam University

E mail: [email protected]

Daejeon, Republic of KOREA

Biography

Jin Ho Lee, graduated Department of Materials Science and Engineering, University of Utah, U. S. A. with Ph. D. degree in 1988. He worked at Biomaterials Laboratory, Korea Research Institute of Chemical Technology (KRICT) as a senior research scientist from 1988 to 1993. Since 1993, he is a professor in the Department of Advanced Materials, Hannam University, Korea. He was the Editor-in-Chiefs of “Biomaterials Research” (Korean Society for Biomaterials, 2003-2007) and “J of Korean Wound Care Soc.” (2007-2010). He served as Secretary General of 7th Asian Symposium on Biomedical Materials (ASBM-7, 2006) and Scientific Program Chair of 2nd TERMIS World Congress (TERMIS-WC, 2009). He also served as a TERMIS-AP Council Member (2009-2011). He was a President of Korean Tissue Engineering and Regenerative Medicine Society (KTERMS) (2012) and served as Conference Chair in TERMIS-AP Daegu Meeting (2014). He was selected as a Fellow of TERMIS in 2015. His recent research area includes stem cells/biocompatible polymer hybrid materials (scaffolds, membranes, microparticles, and hydrogels) for tissue regenerations such as cartilage, bone, tendon, muscle, trachea, vocal fold and nerves. He published more than 220 peer-reviewed journal papers, 35 book chapters, and 55 patents.

Page 46: List of Confirmed Keynote Speakers

Jeong Ok Grace Lim Kyungpook National University School of Medicine Korea

Biography

Dr. Lim received her B.S in Korea, M.S. in Polymers at Cornell University, Ph.D. in Polymer Science at University of Massachusetts Lowell in 1993, and did postdoctoral fellowship at Dr. Langer's lab at MIT, and Harvard Medical School. She was an Assistant Professor at the Wake Forest Institute for Regenerative Medicine (WFIRM) from 2004 through 2006. She was an affiliated faculty member of the Virginia Tech - Wake Forest University School of Biomedical Engineering and Sciences. Currently she is Professor at Kyungpook National University School of Medicine in Korea and adjunct Professor at WFIRM, and of recently organized international center in regenerative medicine which is Joint Institute for Regenerative Medicine (JIRM http://www.jirm.org). Synopsis of area of interest: Dr. Lim has interest in research areas in biomedical applications of biomaterials such as controlled drug delivery systems, tissue engineering, cell therapy; regenerative medicine and novel diagnose system using cell chip technology.

Page 47: List of Confirmed Keynote Speakers

Bin Li Professor of Orthopedic Institute Professor of Department of Polymer Science and Engineering Soochow University Suzhou, Jiangsu, China

Biography

Professor Bin Li received the bachelor degree in Polymeric Materials Science and Chemical Engineering in 1996 and the PhD degree in Materials Science in 2001 from Tsinghua University. He then worked as a Research Associate at the Institute of Materials Research and Engineering, Singapore from 2001 to 2004. After that he pursued postdoctoral training at the Department of Orthopaedics, University of Pittsburgh School of Medicine in USA from 2005 to 2009. He also completed two short-term trainings as a visiting research scientist at Carnegie Mellon University in 2004 and Harvard University in 2009, respectively. He joined Soochow University in 2009 as a Specially Appointed Professor and director of the Biomaterials and Cell Mechanics Laboratory (BCML) of Orthopedic Institute. He is the recipient of a number of awards such as the Orthopaedics Research Award (1st class) from Chinese Orthopaedic Association, Xu Guangqi Program from the French Embassy in China, and France Talent Innovation from the Consulate General of France in Shanghai. He currently serves as the Member-at-Large of the Board of Directors and a member of the China Development Committee of International Chinese Musculoskeletal Research Society (ICMRS). He is a fellow of Chinese Orthopaedic Research Society (CORS), Chinese Association of Orthopaedic Surgeons (CAOS), Chinese Association of Rehabilitation Medicine (CARM), and International Society of Orthopaedic Surgery and Traumatology (SICOT). He is also a member of the Orthopedic Research Society (ORS), Tissue Engineering and Regenerative Medicine International Society (TERMIS), Society For Biomaterials (SFB), Chinese Society for Biomaterials (CSBM), and Chinese Materials Research Society (CMRS). He serves on the editorial board of several journals, including Journal of Orthopaedic Translation, International Journal of Orthopaedics, Chemical Sensors, Soochow University Journal of Medical Science, and Chinese Journal of Tissue Engineering Research, and is the reviewer for over 30 journals. He was the organizing committee and executive chair of the Inaugural ICMRS-ASBMR International Chinese Musculoskeletal Research Conference (Suzhou, 2013). He has given more than 30 invited talks and chaired 16 sessions/symposia. He is the author of over 70 publications and 8 book chapters. His research interests include biomaterials for bone and cartilage repair, stem cells and tissue engineering, smart molecular recognition and controlled release, surface modification and functionalization, cellular biomechanics and mechanobiology.

Page 48: List of Confirmed Keynote Speakers

Guei-Sheung Liu, Ph.D. Research Fellow, Centre for Eye Research Australia Email: [email protected] Melbourne, AUSTRALIA

Biography

Dr Guei-Sheung Liu is a Research Fellow and Group Leader at Centre for Eye Research Australia in Melbourne, Australia. He received his PhD in Biochemistry from the Kaohsiung Medical University (2006) and postdoctoral training in pharmacology/vascular biology from O’Brien Institute (2009-2012). Currently, Dr Liu leads a research group charged with development of genetic therapies for ocular neovascularisation and retinal degeneration. Research in his group is focused on defining hurdles in the translation of ocular gene therapies in order to develop enabling gene delivery and editing technologies. With these optimized technologies, he hopes to partake and lead gene therapies for blindness to the clinic. In addition, Dr Liu has built a strong research track record across key research areas that provide him with a unique insight into novel therapeutic solutions to eye diseases. He currently serves as an editorial board member of PLOS ONE and a reviewer for 20 international peer-reviewed high ranked journals and major research grants.

Page 49: List of Confirmed Keynote Speakers

Feng-Huei Lin, PhD Director, Inst Biomed Eng & Nano-med, National Health Research Institutes (NHRI), Taiwan Distinguished Professor, National Taiwan University (NTU), Taipei, Taiwan Address: Institute of Biomed. Eng., NTU, Taipei, Taiwan

Biography

Dr. Feng-Huei Lin was born in 1957 in Taiwan. He obtained his BS degree in Department of Earth Sciences, National Cheng Kung University (NCKU), Taiwan, in 1980. After served in army for 2 years, he was invited to be a teaching assistant in Department of ES, NCKU, in 1982. In 1983, he joined the Functional Ceramics Lab in Institute of Materials Sciences and Engineering, NCKU, Taiwan. He was assigned to do the research in Bio-ceramic and Composite for Orthopedics; where he received the training both in Materials Technology and Medical Science. During the PhD training, he was not only to take course in engineering school, but also in medical school; that included biochemistry, cell biology, physiology, pathology, anatomy… He was honored as PhD degree with 12 SCI publications in November, 1989. In early 1990, He was recruited as an associate professor in Centre for Biomedical Engineering, College of Medicine, National Taiwan University (NTU); where he started his academic career. In 1997, he promoted to the full professor. He organized to setup the institute of biomedical engineering in NTU and served as acting director in the institute during 1997-1999. He was invited to be the first Engineering background director in Department of Biomedical Engineering, NTU-hospital (2002-2005). In 2005-2008, he back institute of biomedical engineering, NTU, as director. During 2006-2009, National Science Council, Taiwan, asked his help to be the Convener of Biomedical Engineering Division to allocate the budget and to make the future planning in the next 10 years. In 2008-2011, he temporarily transferred to Biomedical Engineering Division, National Health Research Institute, as director and took in charge of Development of Biomaterials and Tissue Engineering. Now, he is the Director of Ins Biomd Eng & Nanomed, National Health Research Institutes, Taiwan (2014-).

Page 50: List of Confirmed Keynote Speakers

Wei Liu Shanghai Tissue Engineering Life Science China

Biography

Prof. Liu graduated from Medical University in 1983 with a MD degree and graduated from University of Arkansas for Medical Science in 1998 with a PhD degree followed by two year postdoctoral training at New York University. He returned to China in 2000. Currently, he is a Professor of Plastic Surgery of Shanghai Jiao Tong University School of Medicine, and Adjunct Professor of Biomedical Engineering of Shanghai Jiao Tong University. He currently serves as Associate Directors of National Tissue Engineering Center of China and Shanghai Institute of Plastic and Reconstructive Surgery. Dr. Liu is the principle investigator of four national key projects of tissue engineering research sponsored by Chinese Ministry of Science and Technology. He is a standing committee member of Chinese Society of Biomaterials and Chinese Society of Tissue Engineering. Dr. Liu is the authors of more than 100 original articles published in international journals, the contributor of several international tissue engineering text books. Dr. Liu is an editorial member of Biomaterials, Journal of Tissue Engineering and Regenerative Medicine, Biomedical Materials, and the Editor of Emerging Issue of Tissue Engineering. He has presented more than 30 invited speeches at various international conferences, including TERMIS-AP and TERMIS-EU chapter meeting and TERMIS-World Congress. Dr. Liu is the organizer of 8th TESI Annual meeting and 2013TERMIS-AP meeting, is a Member-in large of TERMIS-AP, Member of International Union of Societies of Biomaterials Science and Engineering (IUSBSE).

Page 51: List of Confirmed Keynote Speakers

Sung-Jan (Jerry) Lin, M.D., Ph.D. Taiwan Bio-development Foundation (TBF) Chair in Biotechnology Associate Professor of Institute of Biomedical Engineering Vice CEO of Research Center for Developmental Biology and Regenerative Medicine National Taiwan University, Taipei, Taiwan

Biography

Dr. Sung-Jan Lin is the Taiwan Bio-development Foundation (TBF) Chair in Biotechnology and Associate Professor of Institute of Biomedical Engineering and the Vice CEO of Research Center for Developmental Biology and Regenerative Medicine at National Taiwan University. He is also a dermatologist in National Taiwan University. He received his MD in National Taiwan University College of Medicine and PhD. He takes hair follicles, with a distinct structure and the unique arrays of arrangement, as a model to understand how a complex organ is damaged or lost in pathological states, to decipher the principles of organogenesis, to shed light on the repair and regeneration machinery in response to insults. His lab employs a multidisciplinary approach by combing the knowledge in biology and tissue engineering to enhance hair follicle regeneration. He has published ~120 papers. His work has been recognized by Award for Junior Research Investigators in Life Science of Academia Sinica, Physician Scientist Award of Taiwan National Health Research Institutes and Distinguished Research Award of Taiwan Ministry of Science and Technology. In 2014, he was elected as Taiwan Bio-development Foundation (TBF) Chair in Biotechnology.

Page 52: List of Confirmed Keynote Speakers

Ren-Ke Li Cardiovascular Surgery, Toronto General Research Institute, University Health Network Canada

Biography

Dr. Ren-Ke Li, MD, PhD is a Professor of Medicine in the Department of Surgery, Division of Cardiac Surgery at the University of Toronto. Dr. Li is also a Senior Scientist at the Toronto General Research Institute, University Health Network working in the field of stem cell transplantation and tissue engineering. Dr. Li completed his M.D. at Harbin Medical University in China and his Ph.D. in Clinical Biochemistry at the University of Toronto. He became an Assistant Professor at the University of Toronto in 1993 and was promoted to Full Professor in 2002. He is the recipient of the Canada Research Chair in Cardiac Regeneration (Tier 1) of the Canadian Institutes of Health Research and was a Career Investigator of the Heart and Stroke Foundation of Canada. Dr. Li has been on the forefront in the field of cell transplantation and tissue engineering. In 1996, he published the first demonstration that cells transplanted into myocardial scar tissue survived, differentiated into muscle tissue, and improved heart function. His research group has defined optimal cell types and described the optimal conditions for transplantation. Dr. Li has published 209 peer-reviewed papers in very good Journals. He has been invited to contribute several commentaries and viewpoint articles and is an international opinion leader in his field.

Page 53: List of Confirmed Keynote Speakers

Claudio Migliaresi University of Trento Italy

Biography

Full Professor of Materials Science and Technology Director of the Dept. of Industrial Engineering and Dean Head of the Inter-department Research Center BIOtech. Past Academic Career: Director of the Dept. of Materials Eng., Dean of the School of Eng., Professor of Composite Materials Sci. and Technology, Univ. of Trento, Research Associate, Univ. of Napoli, Post-Doc, Univ. of Napoli. Regional Editor of J. of Bioactive and Compatible Polymers and Member of the Editorial Board of several journals (Journal of Biomaterials Applications, Frontiers in bioengineering and biotechnology, International Journal of Biomaterials and others). Current Research deals with Processing and characterization of composite materials, nanocomposites, biomaterials, and materials and technologies for nanomedicine and tissue engineering applications. Over 200 papers in International Scientific Journals, editor of six volumes, several patents.

Page 54: List of Confirmed Keynote Speakers

David Hui-Kang Ma, Ka, M. D., Ph.D Editor-in-Chief of Taiwan Journal of Ophthalmology Professor of Department of Ophthalmology Director of limbal Stem Cell Laboratory Chang Gung Memorial Hospital and Chang Gung University Taoyuan, Taiwan

Biography

David Hui-Kang Ma is a professor of Department of Ophthalmology at Chang Gung Memorial Hospital, Taoyuan, Taiwan. He received his PhD from the Chang Gung University in 2000. He had served as chief of the Cornea Section from 2008 to 2011, later as chairman of the Department of Ophthalmology from 2011 to 2015. From 2003 he has been the director of Limbal Stem Cell (LSC) Laboratory. The main goal of the LSC Laboratory is to conduct clinical trials for cultivated corneal stem cell transplantation. From 2006 to 2009, the LSC Laboratory had completed an IRB and government-monitored Phase Ia clinical trial for cultivated autologous oral mucosal epithelial cell transplantation (COMET) for the treatment of severe ocular surface diseases caused by limbal epithelial stem cell deficiency. A Phase Ib trial has now been approved by TDFA. At the same time, the LSC Laboratory is in collaboration with Chang Gung University for developing biomaterials suitable as carrier for cultivated corneal epithelial or endothelial cells for transplantation. The results have been published in prestigious journals like Biomaterial, Acta Biomaterialia, Journal of Biomedical Nanotechnology, etc.

Page 55: List of Confirmed Keynote Speakers

Hai-Quan Mao Professor Department of Materials Science and Engineering, Whiting School of Engineering Translational Tissue Engineering Center, School of Medicine Institute for NanoBioTechnology Whitaker Biomedical Engineering Institute Johns Hopkins University

Biography

Dr. Hai-Quan Mao received his Ph.D. in polymer chemistry in 1993 from Wuhan University in China, and completed his postdoctoral training in the Department of Biomedical Engineering at Johns Hopkins University School of Medicine from 1995 to 1998. He then joined Johns Hopkins in Singapore as a co-principal investigator for the Tissue and Therapeutic Engineering Laboratory from 1998 to 2003. There he also taught at the Department of Materials Science in the National University of Singapore as an adjunct assistant professor from 2001 to 2003. Dr. Mao joined the Department of Materials Science and Engineering and the Whitaker Biomedical Engineering Institute at the Johns Hopkins University as an assistant professor in 2003, was promoted to associate professor with tenure in 2009, and to full professor in 2013. Currently, Prof. Mao serves as an associate director for the Johns Hopkins Institute for NanoBiotechnology; he is also a member of the Translational Tissue Engineering Center at Johns Hopkins School of Medicine. Dr. Mao’s research focuses on engineering nanomaterials for molecular therapy and for regenerative medicine applications. He has published 112 peer-reviewed articles and 18 issued US patents and more than a dozen of provisional patent applications. His research received the Capsugel Awards for Outstanding Research from the Controlled Release Society in 1998, the Young Investigator Award from the National University of Singapore in 2002, the Faculty Early Career Award from the National Science Foundation in 2008. Dr. Mao is also a Fellow of Royal Society of Chemistry. He currently serves as an Associate Editor of Biomaterials, and is a member of the Editorial Advisory Boards of ACS Biomaterials Science and Engineering, and Journal of Materials Chemistry B.

Page 56: List of Confirmed Keynote Speakers

Hong Wei Ouyang Professor in Sports medicine & Stem Cells and Regenerative Medicine, Director for School of Basic Medical Science, Zhejiang University Hangzhou City, Zhejiang Province,China

Biography

Professor Ouyang focuses on the research of tissue engineering and regenerative therapy of tendon and cartilage. With the development of a functional silk scaffolds as well as the stepwise differentiation of embryonic or adult stem cells with the combination of biochemical and mechanical strategies, Prof Ouyang’s researches improved structural and functional tendon and cartilage regeneration significantly in vitro and in vivo.He has filed fifteen national patents applications (eight approved) and published more than sixty original research papers in the international journals. These papers corresponded by Prof Ouyang were published in the leading journals of particular fields, such as Stem Cells, Biomaterials, Cell Transplantation( Average IF=6). In 2008, authorized by State Food and Drug Administration, he was involved in drafting the Guide for in vivo assessment of implants for cartilage repair and regeneration YY/T 0606.10-2008, Chapter 10 of Tissue Engineering Medical Products, Pharmaceutical Industry Standard of People’s Republic of China. In 2009, he was again involved in formulating the Provisions for Therapeutic Transplantation of Engineered Tissues announced by the Ministry of Health(MOH). In March of 2010, under the new regulations of the Ministry of Public Health in China, Prof Ouyang established a standard approach for tissue engineered cartilage (TEC) transplantation, and set up the clinical application network of cartilage tissue engineering technology in orthopedics from five third-grade class-A hospitals in Zhejiang.

Page 57: List of Confirmed Keynote Speakers

Guoxian Pei Nanfang Hospital China

Guoxian Pei, the Professor and Chairman of Department of Orthopaedic Surgery, Xijing Hospital, The Fourth Military Medical University; Chairman of Chinese Microsurgery Society; He was served as the fifth Academic Degree Committee of the State Council subject review group,National Prize for progress in science and technology evaluation expert, the general secretary of International composite tissue allotransplantation, the member of Aian Orthopaedic Trauma Association, the primary chairman of Chinese Microsurgery Society, the Chief Editor of Chinese Journal of Orthopaedic Trauma.

Professor Pei Guoxian is a well-known expert in the fields of orthopedic trauma, microsurgery, and hand surgery, especially microsurgical techniques for highly complex orthopedic applications. He has introduced a number of new theories and new techniques in severe limb trauma treatment and formed a relatively complete theory and clinical treatment system; he has also made a number of internationally advanced innovative achievements. He was the first to report on the success of four-limb replantation for one patient in the international arena; the first to create the new microsurgical technique called the “double bridges type flap for reconstruction” for lower limb severe trauma to avoid amputation; and the first to introduce limb allotransplantation in Asia and successfully carry out an allogeneic hand transplantation, which were the first and the second cases in Asia (3rd and 4th cases in the world), which became part of the “Chinese Top Ten Medical Technology news in 2000.” He was the first one in the international community who proposed the new theory of blood vessels, nerves, tissue-engineered tissues and organ-synchronized construction. More recently he has constructed compound tissues successfully and the results have entered into the early stages of clinical application. Professor Pei has been the editor of 12 monographs including The Hand Surgical Anatomy and Clinic; Microscopic Hand Surgery; and Transplantation of Allogeneic Limbs; and has published 156 treatises as the first corresponding author in the domestic and international fields, including 26 articles collected by SCI. He has also headed 17 foundations of the 863 national major projects, the 973 national projects, the major projects of the National Natural Science Foundation, the Army Outstanding Young Talent Fund, and the Army Key Research Fund. He has received 14 science and technology awards as the first corresponding author, including one National Science and Technology Progress Award, three Provincial Technological Progress Awards, and two Major Technology Achievement Awards, and has registered 6 national invention patents. Professor Pei has received the “First National Young Medical Technology Star”, “National Outstanding Young Scientific and Technical Experts” and “First Candidate of Millions Talents Project” awards, the General Logistics Department’s “Excellent Talents of Science and Technology in the Army” award, was among the first group of “Candidate Sciences Academician of the General Logistics Department”, and received the “Army Significant Contribution Award of Professional Technology”.

Page 58: List of Confirmed Keynote Speakers

Yelena Parfyonova Professor of Institute of Experimental Cardiology, Head of Angiogenesis laboratory, Russian Cardiology Research and Production Center; Professor of Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia

Biography

Yelena V. Parfyonova is a Professor of Cardiology at Russian Cardiology Research and Production Center. She received her MD from the 2nd Moscow Medical Institute (now Pirogov’s Russian National Research Medical University), and her Ph.D. in Cardiology and Biochemistry from Russian Cardiology Research and Production Center. Her lab works on molecular and cellular mechanisms of blood vessel remodeling and angiogenesis with focus on understanding and exploiting the role of uPA system, angiogenic properties of adipose-tissue derived stem cells (ASCs). The lab also works on the application of gene and cell therapy for ischemic diseases, particularly on developing plasmid-base gene therapy using combination of angiogenic growth factor genes and genetically modified ASCs. For the last five years the lab has been involved in studying cardiac stem cells and their application for cell sheets technology. Since 2005 she also works as a faculty in the Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Lomonosov Moscow State University. She has published 187 peer-reviewed research papers in international and national journals and holds more than 10 issued patents. She is a member of the Russian Societies of Cardiology, Endocrinology and Regenerative medicine, and the American Society of Gene and Cell therapy, and also a member of the Boards of Expert of Russian Ministry of Education and Science (Life Science expert group), Russian Ministry of Health, and Skolkovo Foundation.

Page 59: List of Confirmed Keynote Speakers

Kwideok Park Principal Research Scientist Center for Biomaterials, Korea Institute of Science &Technology Professor, Head of Department of Biomedical Engineering University of Science and Technology, Seoul, Republic of Korea

Biography

Kwideok Park is the principal research scientist at Korea Institute of Science and Technology (KIST). He received his PhD in Biomedical Engineering from the University of Iowa. His major research interest is extracellular matrix (ECM)-based microenvironments that is a very critical issue in tissue engineering. His lab utilizes cell-derived extracellular matrix (CDM) as a research platform. CDMs have been fully characterized and evaluated for multi-lineage differentiation of hMSCs and for vascular morphogenesis of endothelial cells. These matrices are also chemically modified either for a growth factor delivery or for stiffness-controlled matrices. In addition, human matrix is coupled with biocompatible polymers for translational research. He has published more than 70 peer-reviewed papers and wrote several book chapters. Dr. Park is currently a council member of TERMIS-AP and an active member of Korean Society for Biomaterials, Korean TERM, and TERMIS. He also serves as an editorial board member of Journal of Regenerative Medicine and Tissue Engineering, Tissue Engineering and Regenerative Medicine, and Biomaterials Research.

Page 60: List of Confirmed Keynote Speakers

Heinz Redl Director Ludwig Boltzmann Institute for Experimental and Clinical Traumatology Vienna, Austria

Biography

Heinz Redl PhD has a background in biochemistry and ultrastructural research with > 35 years experience in trauma research and holds the position of an Associated Professor at the Technical University Vienna, Institute for Chemical Engineering. He is director of the Ludwig Boltzmann Institute of experimental and clinical Traumatology within the main trauma research center of AUVA representing 7 trauma and 4 rehabilitation centers, professor at the Technical University Vienna, and coordinator of the Austrian Cluster for Tissue Regeneration. He is/has been member/officer of several societies including next president TERMIS-EU and editorial boards (e.g. Tissue Eng., J.TERM, European Cells and Materials J.), founder of Trauma Care Consult company, co-founder of Liporegena and consultant for multiple companies covering product registration at FDA and EMA. He has also organized many conferences incl. the world congress TERMIS 2012 and workshops (Winterschool Radstadt). His expertise includes: Experience in different fields of tissue regeneration, co-developer of the fibrin sealant system (>30 years), developer of surgical devices in current clinical use and many collaboration projects with major industry partners. >460 Medline cited papers, >10 patents. He has also participated in several EC projects including e.g. NoE Expertissues, Angioscaff, Biodesign, IMCOSS, UGEN.

Page 61: List of Confirmed Keynote Speakers

Rui Reis Professor Department of polymer engineering University of Minho Portugal

Biography Professor Rui L. Reis, PhD, DSc, Hon. Causa MD, 48 years old, is the Vice-President for R&D of University of Minho (UMinho) in Portugal, Director of the 3B’s Research Group on Biomaterials, Biodegradables and Biomimetics (www.3bs.uminho.pt) and of the ICVS/3B´s Associate Laboratory (around 430 researchers), of UMinho. He is the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine (TERM), the President and CSO of the company Stemmatters, the President-elect of Global TERMIS (will be President from 2016-2018) and the editor-in-chief of the Journal of Tissue Engineering and Regenerative Medicine (IF= 5.2). He is co-author of 895 ISI listed publications (735 full papers in scientific journals), around 220 book chapters, 30 patents and 8 books. He has around 1700 communications in international conferences. He is PI of projects totalizing around 30 MEuros, including the very prestigious ERC Advanced Grant and an ERA Chairs. He runs a research group of around 175 researchers with more than 70 PhD holders. He was been awarded several major national and international scientific and innovation awards in Europe and the USA, including the Jean Leray and George Winter awards from ESB and the Clemson Award for Contributions to the Literature from SFB. He is both a fellow of TERM (FTERM from TERMIS) and an International Fellow of Biomaterials Science and Engineering (FBSE).

Page 62: List of Confirmed Keynote Speakers

Masato Sato Professor Department of Orthopaedic Surgery, Surgical Science, Tokai University School of Medicine Japan

Biography MEDICAL LICENSURE Medical License #344096, Japan, 1991. Board-certified Orthopedic Surgeon #112894, The Japanese Orthopedic Association, 1997. Specialist for Rheumatologist #4423, The Japanese Orthopedic Association, 1998. Registered Doctor #4813, Japan Rheumatism Foundation, 1999. Board-certified Rheumatologist #3145, Japan College of Rheumatology, 2000. Board-certified Spine Surgeon #10823, The Japanese Society for Spine Surgery and Related Research, 2003. Instructor # 090808001, Japan Society for Laser Surgery and Medicine, 2003. Specialist for Spinal Cord Diseases #1107, The Japanese Orthopedic Association, 2004. Guidance Specialist #1569, Japan College of Rheumatology, 2010. Guidance Specialist # M1-2015-00257, The Japanese Society for Regenerative Medicine, 2015. PRESENT POSITION AND ACADEMIC RANK 2013 - Present Professor, Department of Orthopaedic Surgery, Surgical Science, Tokai University, School of Medicine. 2012 - Present Director, Research Source Bank, Tokai University, School of Medicine. 2010 - Present Director, Cell Processing Center, Tokai University Hospital. PREVIOUS PROFESSIONAL POSITIONS AND APPOINTMENTS 2007 - 2013 Associate Professor, Department of Orthopaedic Surgery, Surgical Science, Tokai University, School of Medicine. 2003 - 2007 Assistant Professor, Department of Orthopaedic Surgery, Surgical Science, Tokai University, School of Medicine. 2002 - 2003 Adjunct Assistant Professor, Department of Medical Engineering, National Defense Medical College. 2001 - 2003 Director, Department of Orthopaedic Surgery, Self Defense Force Hospital Yokosuka. EDUCATION/POST GRADUATE TRAINING College/University: 1997 - 2001 Ph.D., National Defense Medical College, Saitama, Japan., and National Institution for Academic Degrees and University Evaluation, Kodaira, Tokyo. 1985 - 1991 M.D., National Defense Medical College, Saitama, Japan. Training: 1995 - 1997 Orthopaedics Specialized Training, National Defense Medical College, Japan. 1994 (6 months) Tripler Army Medical Center, USA.

Page 63: List of Confirmed Keynote Speakers

Tatsuya Shimizu Tokyo Women's Medical University Japan

Biography

Dr. Tatsuya Shimizu is professor of Institute of Advanced Biomedical Engineering and Science (ABMES), Tokyo Women’s Medical University (TWMU). He graduated from Faculty of Medicine, the University of Tokyo and got medical doctor (M.D.) in 1992. After two-year clinical training, he made a specialty of cardiovascular medicine including catheterization and got Ph.D in 1999. After that, he moved to ABMES of TWMU as a research assistant professor and started myocardial tissue engineering research based on “cell sheet technology”. Cell sheet technology is very unique and has realized clinical application for several types of regenerative therapies. Furthermore thick cell-dense tissues have been successfully engineered by stacking cell sheets and introducing blood vessels. His recent work is engineering tubular heart-like organ, 3-D tissue model systems for heart, liver and kidney, additionally, automatic tissue fabrication system (T-Factory).

Page 64: List of Confirmed Keynote Speakers

Martin J. Stoddart, PhD, FRSB AO Research Institute Davos, Email: [email protected] Davos Platz, SWITZERLAND

Biography

Since 2009 Martin Stoddart has been a Principal Scientist at the AO Research Institute (ARI), responsible for the Stem Cell Focus Area. His interests include the use of mesenchymal stem cells for bone and cartilage repair.

He completed his doctoral thesis in Oncology (University of Nottingham 1999). In 2002 he took a sabbatical at the Centre for Molecular Orthopeadics, Harvard Medical School, Brigham and Womens Hospital, Boston, to learn viral gene transfer techniques. He is an Honorary Professor, Albert-Ludwigs University, Freiburg, Germany and University of Keele, UK. In 2016 he was elected Fellow of the Royal Society of Biology. He is the author of over 70 papers, is Chair of the ORS Basic Science Education Committee and a member of the ICRS Communication and Publication Committee. He is an Editor for Tissue Engineering Journal Parts A,B,C, Scientific Editor for eCM Journal and an organizer of the yearly eCM Conference.

Page 65: List of Confirmed Keynote Speakers

Wei Sun Albert Soffa Chair Professor- Drexel University, National "Thousand-Talent" Distinguished Professor- Tsinghua University China

Biography

Dr. Wei Sun is currently appointed as National “Thousand-Talent” Distinguished Professor and Director of Biomanufacturing Research Center at Tsinghua University, China, and Albert Soffa Chair Professor of Mechanical Engineering at Drexel University, USA. Dr. Sun’s research has been on Biofabrication, 3D Bio-Printing, Computer-Aided Tissue Engineering, and Additive Manufacturing. He has received funding support from US National Science Foundation (NSF), Defense Advanced Research Projects Agency (DARPA), National Aeronautics and Space Administration (NASA), Chinese Natural Science Foundation (CNSF) and Chinese Ministry of Science and Technology. He has published over 350 journal and conference papers/abstracts and conducted over 210 national and international invited presentations in the field of his research. Dr. Sun is Editor-in-Chief for international journal Biofabrication and the founding President for International Society of Biofabrication.

Page 66: List of Confirmed Keynote Speakers

Hsing-Wen Sung, Ph.D.

Tsing Hua Distinguished Chair Professor Department of Chemical Engineering Director Institute of Biomedical Engineering National Tsing Hua University Hsinchu, Taiwan (ROC) Email: [email protected]

Biography

Hsing-Wen Sung is a Tsing Hua Distinguished Chair Professor, Department of Chemical Engineering and the Director of Institute of Biomedical Engineering, National Tsing Hua University, and the President of Society of Biomaterials and Controlled Release of Taiwan. He received his PhD degree from Department of Chemical Engineering/Biomedical Engineering Center, Georgia Institute of Technology in May 1988. His research interests are biomaterials, nanomedicine, drug/gene delivery, and tissue engineering. Professor Sung has received numerous awards such as Fellow of American Institute for Medical and Biological Engineering, Fellow of International Union of Societies for Biomaterials Science and Engineering, Academician of Asia Pacific Academy of Materials, Ho Chin Tui Outstanding Research Award, National Science Council Outstanding Research Award, and Professor Tsai-The Lai Award. He has been on the Editorial Boards of Journal of Controlled Release, Tissue Engineering, and Advanced Healthcare Materials; also, he has been serving as a Handling Editor for Biomaterials. Professor Sung has published 240 scientific papers and received 70 international patents.

Page 67: List of Confirmed Keynote Speakers

Kohei SOGA, Ph. D. Professor Department of Materials Science and Technology Tokyo University of Science, Japan E-mail: [email protected]

Biography

Dr. Kohei SOGA started his research on rare-earth-doped luminescent materials in 1990 as a graduate student of the University of Tokyo. His thesis concentrated on relating the spectroscopic properties of the rare earth ions and the structure of the host glass. After obtaining the Ph. D. degree in 1995, he explored his research onto the photonic applications, especially on that relating to optical communication. Beside the work on physical properties of icosahedral cluster solids started in 2000, he has extended the materials to nanophosphors. Since 2004, he has challenged to develop biophotonic system under near infrared excitation as an interdisciplinary research by bio-nano-photonics collaboration. The research is attracting the interests from the researchers in medicine, biomaterials, photonic materials and bioengineering. He has authored and co-authored 145 journal papers and presented totally more than 460 oral and poster presentations including 55 invited presentations.

Page 68: List of Confirmed Keynote Speakers

Yasuhiko Tabata Professor and Chairman, Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University Japan

Biography

Dr. Yasuhiko Tabata is the Professor and Chairman of the Department of Biomaterials at the Institute for Frontier Medical Sciences, Kyoto University and serves as adjunctive professor at 14 different universities. He received his BD in Polymer Chemistry (1981), Ph.D. (1988) in Technology, D.Med.Sc. (2002), and D.Pharm. (2003) all at Kyoto University. He received the Young Investigator Award (1990), the Scientific Award from the Japanese Society for Biomaterials (2002), the Scientific Award from the Japan Society of Drug Delivery System (2011), the Scientific Award from the Japanese Society for Regenerative Medicine (2014), and several awards. He has published 1,280 scientific papers including 120 book chapters and review articles, and has 130 patents. Dr. Tabata is the Board Governor of 5 Japanese Academic Societies or an associate member of the Science Council of Japan, Cabinet Office and the Editorial Board of 7 scientific journals. Specific research interests include biomaterials, drug delivery system (DDS), tissue engineering, stem cell technology, and medical diagnostics.

Page 69: List of Confirmed Keynote Speakers

Ching-Li Tseng, Ph. D. Assistant Professor, Taipei Medical University (TMU) Email: [email protected] Taipei, Taiwan

Biography

Dr. Tseng is currently an assistant professor at Taipei Medical University. She focuses her research on non-invasive way to deliver nanoparticles for disease treatment, for example inhalation of nanomedicine for treating lung cancer and eye-drops with nanoparticles for ophthalmic application. An eye-drop contained tea polyphenol loaded nanoparticles for dry-eye syndrome and corneal neovascularization treatment has been investigated, and results show its potential to be an effective formulation for treating these diseases.

Dr. Tseng serves as a reviewer for many international journals. She was the secretary general of the International Symposium of Materials on Regenerative Medicine (ISOMRM, Taiwan) in 2012 contributing great efforts for organize successful scientific events. She received awards including “Excellent Award of Research day from National Health Research Institute”, “Young Investigator Award from the 3rd ISOMRM and the 7th World Congress on Preventive and Regenerative Medicine (WCPRM, Taiwan) etc. She also guided student to win the poster award of Ocular Drug Delivery Focus Group in the Annual meeting of American Association of Pharmaceutical Scientists (AAPS), 2015.

Page 70: List of Confirmed Keynote Speakers

Shoji Takeuchi Professor, University of Tokyo Tokyo, JAPAN

Biography

Dr. Takeuchi obtained his B.E, M.E., and Ph. D. degrees in Mechanical Engineering from the University of Tokyo, Japan. He is currently a Professor in the Center for International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science (IIS) at the University of Tokyo. His current research interests include 3D tissue fabrication, implantable devices, artificial lipid bilayer systems, and biohybrid MEMS. His research earned him recognition through numerous prestigious awards including the Young Scientists' Prize, the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology in 2008, and the JSPS prize from the Japan Society for the Promotion of Science in 2010. ACS Analytical Chemistry Young Innovator Award in 2015.

Page 71: List of Confirmed Keynote Speakers

Takashi Ushida Editor-in-Chief Emeritus, Journal of Biomedical Science & Engineering Professor of Department of Mechanical Engineering Professor of Bioengineering University of Tokyo Tokyo, Japan

Biography

Takashi Ushida is Professor of Mechanical Engineering & Bioengineering at University of Tokyo. He was the Editor-in –Chief of Journal of Biomechanical Science and Engineering (JBSE), a fellow and former chairman and a member of steering committee of Bioengineering Division, Japan Society of Mechanical Engineers (JSME), a council member of World council for Biomechanics (WCB). He is also council members of Japanese Society of Regenerative Medicine (JSREM), Japanese Society of Clinical Biomechanics (JSCB), Japanese Society for Biomaterials (JSB). His research interests include tissue regeneration especially cartilage regeneration, cellular effects of physical stimulation especially chondrocyte differentiation and cartilage tissue reconstruction under physiological hydrostatic pressure loading, and noninvasive measurements of regenerated tissues. He has 140 peer reviewed scientific papers and 10 national / international awards.

Page 72: List of Confirmed Keynote Speakers

Anthony Weiss Sir Samuel McCaughey Chair in Biochemistry Professor of Biochemistry and Molecular Biotechnology Molecular Bioscience | Faculty of Science THE UNIVERSITY OF SYDNEY Australia

Biography Professor Weiss is the Sir Samuel McCaughey Chair and Professor of Biochemistry & Professor of Molecular Biotechnology in the School of Molecular Bioscience at the University of Sydney. He is affiliated with the Charles Perkins Centre, Bosch Institute, and Royal Prince Alfred Hospital. He is a Fellow of the Royal Society of Chemistry, Fellow of the Australian Academy of Technological Sciences and Engineering, Fellow of the American Institute for Medical and Biological Engineering, Fellow of the Royal Society of Arts, Fellow of the Australian Institute of Company Directors, Royal Australian Chemical Institute Chartered Chemist. He is on the Editorial Boards of ACS Biomaterials Science and Engineering (American Chemical Society), Biomacromolecules (American Chemical Society), Biomaterials (Elsevier), Biomedical Materials (IOP), BioNanoScience (Springer) and Tissue Engineering (Liebert). He has twenty-six awarded patents, is a serial entrepreneur, biotechnology company founder, promoter of national and international technology development, and is recognized with an array of national and international awards and prizes. He is the world leader in human tropoelastin research and synthetic human elastin. His lab is making human elastic materials that accelerate the healing and repair of arteries, skin and other 3D human tissue components.

Page 73: List of Confirmed Keynote Speakers

Wutian Wu, MD, PhD Professor School of Biomedical Sciences LKS Faculty of Medicine The University of Hong Kong HKSAR, China

Biography Wutian Wu, graduated from Sun Yat-Sun University Medical Sciences in 1975, obtained MS degree from the same University in 1981 and PhD degree from Eastern Virginia Medical School, Virginia, USA in 1991. Since 1996, Dr Wu has been working as assistant professor to professor in the Department of Anatomy, LKS Faculty of Medicine, The University of Hong Kong. His research focuses on neuronal injury and axonal regeneration. He has received over 30 research grants. Dr Wu has published over 140 peer review papers in international journals such as Nature Medicine, Nature Methods, PNAS, Development, Exp Neurol, Brain Res, J Neurotraum and received good citation.

Page 74: List of Confirmed Keynote Speakers

Chengtie Wu, Ph.D Professor, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China. Email: [email protected] (C.Wu)

Biography

Prof. Chengtie Wu is now working in Shanghai Institute of Ceramics, Chinese Academy of Sciences (SIC, CAS). He completed his Ph.D in 2006, and then he worked in the University of Sydney, Dresden University of Technology, Germany and Queensland University of Technology where he was awarded Vice-Chancellor Research Fellow, APDI Fellow and Alexander von Humboldt Fellow. In 2012, Dr Wu has been recruited to work in SIC, CAS, as One-Hundred Talent Program of Chinese Academy of Sciences. Then he was awarded Recruitment Program of Global Young Experts of China (One-Thousand Young Talent Program), Shanghai Pujiang Talent Program and Shanghai Outstanding Academic Leaders. Prof Wu’s research focuses on bioactive inorganic materials for bone tissue engineering. Up to now, Prof Wu has published more than 140 SCI peer-review journal papers, including Mater Today, Adv Funct Mater, Biomaterials, Chem Sci, Adv Mater Interface, Small, J Control Release, Acta Biomater, Carbon, J Mater Chem, ACS Appl Mater& Interface, Bone, Tissue Eng. etc. The papers have been cited more than 3600 times, H Index 35 via SCI, Web of Science. Prof Wu has been awarded 14 patents, in which 3 of them have been transferred to companies.

Page 75: List of Confirmed Keynote Speakers

Ching-Jen Wang ,M.D. Professor, Kaohsiung Chang Gung Memorial Hospital & Chang Gung University College of Medicine, Kaohsiung, Taiwan Email: [email protected]

Kaohsiung, TAIWAN

Biography

Medical school: Graduated from National Taiwan University College of Medicine, Taiwan in 1965. Research fellowship at HSS 1972-1973 under Peter S. Walker, PhD. Personal experiences: Practice in Orthopedic Surgery in New Jersey, from 1972 to 1997.

Superintendent (1997 to 2003) and.honorary superintendent (2003 to present) of Kaohsiung Chang Gung Memorial Hospital,Taiwan.

Academic appointment: Professor (1997-2004), clinical professor (2003-present) of Orthopedic Surgery, Chang Gung University, college of medicine,Taiwan.

Has published 220 scientific papers (most are SCI articles) and many international and national presentations.

Awards: Best poster award from AAOS (Am Academy of Orthopedic Surgeons) annual meeting in San Francisco in 2008. Best research paper from Taiwan Orthopedic Research Society in 2008. Outstanding paper from Chang Gung Medical Journal in 2007 and 2010. Bronze medal award and NSQ (National Symbol of Quality), Taiwan Biotechnology Institution 2011.

Areas of interest: Sports injury and ligament reconstruction of the knee, total joint (knee and hip) and shockwave medicine.

Page 76: List of Confirmed Keynote Speakers

Xuebin Yang MD, MSc, PhD, Head of Tissue Engineering Research Biomaterials and Tissue Engineering Research Group Leeds Dental Institute, University of Leeds, United Kingdom Tel: +44 113343 6162, E-mail: [email protected]

Biography Dr Xuebin Yang (XY), the head of tissue engineering research at School of Dentistry, University of Leeds, UK, is also a ‘Concurrent Professor’ in Nanjing University, China (2009-), ‘Invited Professor’ in Tokyo

Women’s Medical University, Japan (2011-) and ‘Honorary Professor’ in School of Medicine, Henan

University of Science and Technology, China (2012-). His research profile combines 12 years’ expertise in clinical orthopaedics with highly specialised research expertises (Since 1999) in skeletal tissue engineering using stem cell therapy, biomimetic biomaterials and in vitro, in vivo models. Originally an orthopaedic surgeon, XY completed his primary medical education in 1984. Subsequently, he was awarded an MSc degree in hand and microsurgery (1992, Fudan University, PR China) and a PhD degree in bone tissue engineering (2002, University of Southampton, UK). XY currently lead a team of 12 PhD students and 1 fellow who are working on stem cell therapy and skeletal tissue engineering in regenerative medicine and dentistry. XY holds a Home Office Project License for 8 different in vivo models for pre-clinical testing of the efficacy of stem cell therapy and/or biomaterial scaffolds. He plays a key role in the University’s major tissue engineering and regenerative medicine research programmes (WELMEC, CDT, LMBRU and Regener8). He developed and provide leadership (PIs) for six international consortia which include partners in USA, Japan, New Zealand, China, Australia and EU countries. XY has been the Honorary Treasurer and Trustee of the British Orthopaedic Research Society, the vice-president of the Luoyang Hand Surgery Society, a member of the scientific committees for many prestigious conferences, grant review panels (e.g. FP7, Horizon 2020, NSFC) and editorial board for professional journals.

Page 77: List of Confirmed Keynote Speakers

Shengmin Zhang Professor of Department of Biomedical Engineering Professor of Biomaterials and Tissue Engineering Director of Advanced Biomaterials and Tissue Engineering Center

Huazhong University of Science and Technology

Biography

Dr. Shengmin Zhang received his Ph.D. in Biomedical Materials from Wuhan University of Technology, China. Starting in 2003 he became the Chair Professor and Director of the Advanced Biomaterials and Tissue Engineering Center at Huazhong University of Science and Technology in Wuhan, China. His previous academic positions were Professor (2000-2003), Associate Professor (1996-2000) and Assistant Professor (1992-1996) in Materials Science at Wuhan University of Technology. Prof. Zhang has over 20-year experience in biomaterials and tissue engineering fields and has authored more than 100 original papers, 5 books and given about 50 keynote or invited speeches in various conferences. He is the inventor of more than 30 patents, some of which were further developed into two medical device products authorized by CFDA. Dr. Zhang very actively serves the society committees and leads numerous significant academic activities. He is Chairman of Regenerative Medical Materials Committee, Chinese Society for Biomaterials (CSBM) and CSBM Chairman of Science Popularization Committee. He has initiated and chaired several international conferences and has been one of few key leaders in promoting collaborative research between Chinese and Korean biomaterials communities. He serves on the editorial boards of several well-established international journals, such as Tissue Engineering, Biomedical Materials (IOP, UK), etc.

Page 78: List of Confirmed Keynote Speakers

Xing Zhang Shenyang National Lab. for Materials Science, Institute of Metal Research, Chinese Academy of Sciences China

Biography

Dr. Xing Zhang received his Ph.D. degree in Materials Science and Engineering from the University of California, San Diego in 2007. He worked as a Research Scientist for development of nano hemostatic agents in Provex Technologies company from 2007-2008. He subsequently conducted his post-doctoral research work on kidney tissue engineering in School of Medicine at the University of California, San Diego from 2008-2011. He further performed post-doctoral research work on heart valve tissue engineering in Bioengineering Department at Rice University from 2011-2013. In June 2013, he was appointed as a faculty member in Shenyang National Laboratory for Materials Science at Institute of Metal Research, Chinese Academy of Sciences. Dr Zhang’s research has been focused on biomaterials for bone defect repair and heart valve tissue engineering. He is a member of Materials Research Society, Society For Biomaterials (USA), and Chinese Society For Biomaterials. He also serves as associate editor for the journal Experimental Techniques, and guest editor for the journal Materials Technology.

Page 79: List of Confirmed Keynote Speakers

Yongjie Zhang Professor yongjie zhang, R&D Center for Tissue Engineering,

Fourth Military Medical University, Xian City, Zhejiangshaanxi Province,

China.

Biography

Professor Yongjie Zhang focuses on the research and development of tissue engineering and regenerative medicine production, such as skin, cornea, bone, cartilage, and so on. As a key member, He developed the first tissue engineering product – tissue engneering skin, Activskin, in China, ActivSkin has two layers like native skin, stratified epithelial layer and dermal layer. And he took part in the development of the first tissue engineering cornea product, which was decellularized porcine cornea as the cornea substitutes, and approved by State Food and Drug Administration in 2015. He was involved in drafting 2 Industry Standard of People’s Republic of China. He got the 1st class reward of national technology improvements in 2011. He was elected to the Secretary General of Chinese society of tissue engineering and regenerative medicine in 2013.

Page 80: List of Confirmed Keynote Speakers

Zhi-Yong Zhang, PhD Professor in Shanghai 9th People’s Hospital, School of Medicine, Shanghai Jiao Tong

University, P.R. China;

Principle Investigator and Group Leader in National Tissue Engineering Center of China &

Shanghai Key Laboratory of Tissue Engineering;

Awardee of National "1000 Young Talent" plan, P.R. China;

Shanghai “Eastern Scholar” Distinguished Professor, P.R. China.

Biography

Professor Zhang Zhiyong received his B.Sc. degree in biology from Xiamen University of China in 2004 and PhD degree in bioengineering from National University of Singapore in 2009. From 2010 to 2012, he held an adjunct position in Fourth Military Medical University as Associate Professor. In 2012, he joined Shanghai Jiao Tong University and National Tissue Engineering Center of China as Professor and Group Leader; meanwhile he was granted National "1000 Young Talent" Award by the central government of China and appointed as “Eastern Scholar” Distinguished Professor by Shanghai government. Trained as a bioengineer at multidisciplinary interfaces, Prof. Zhang holds great passion for translational research of bone tissue engineering and regenerative medicine (TERM). He is pioneering in the use of allogenic fetal mesenchymal stem cell source for TERM application and successfully developed an off-the-shelf bone TERM strategy with the integrated use of stem cell, scaffold, and bioreactor. Currently, the first-in-man clinical trial of this strategy has been approved by the Health Sciences Authority of Singapore (the regulatory agency counterpart of US FDA). He has filed more than 10 patents, published more than 30 academic papers in the prestigious international journals such as Stem Cells, Biomaterials, Cell Transplantation and Tissue Engineering (Average IF: 5.3 per paper) and authored five bookchapters. He has given plenary, keynote, invited presentation in more than 30 international conferences and been granted 12 scientific awards including the Natural Science Award of Ministry of Education of China (the First Prize, 2014) and so on. In addition, he has successfully secured 10 research grants with more than 10 million RMB research grants in China and serves in more than 10 academic societies. His research effort has also led to the successful commercialization and clinical translation of a unique bioreactor device and 3D printed surgical guide for total knee replacement surgery. Recently he was invited to become the committee member of Tissue Engineering Technical Committee in Standardization Administration of China (SAC, the counterpart of ISO) and helps to draft three industry standards for bone tissue engineered products.